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Abstract
Stroke is a pervasive, devastating disease and remains one of the most
challenging conditions to treat. In particular, risk of recurrence is
dramatically heightened after a primary stroke and requires urgent
preventative therapy to effectively mitigate. However, the appropriate
preventative therapy depends on the underlying source of the stroke, known
as etiology, which is challenging to determine promptly. Current diagnostic
tests for determining etiology underwhelm in both sensitivity and specificity,
and in as much as 35% of cases etiology is never determined. In ischemic
stroke, the composition of the occluding thrombus, specifically its red blood
cell (RBC) content, has been shown to be indicative of etiology but remains
largely ignored within clinical practice. Currently, composition can only be
quantified through histological analysis, an involved process that can be
completed in only the minority of cases where a thrombus has been physically
retrieved from the patient during treatment.
The goal of this thesis is to develop a quantitative MR imaging method which
is capable of non-invasive prediction of ischemic stroke etiology through
assessment of thrombus RBC content. To achieve this goal, we employed
quantitative MR parameters that are sensitive to both RBC content and
oxygenation, R2* and quantitative susceptibility mapping (QSM), as well as
fat fraction (FF) mapping, and evaluated the ability of modern artificial
intelligence techniques to form predictions of RBC content and etiology based
on these quantitative MR parameters alone and in combination with patient
clinical data.
First, we performed an in vitro blood clot imaging experiment, which sought
to explicitly define the relationship between clot RBC content, oxygenation
and our quantitative MR parameters. We show that both R2* and QSM are

ii
sensitive to RBC content and oxygenation, as expected, and that the
relationship between R2* and QSM can be used to predict clot RBC content
independent of oxygenation status, a necessary step for stroke thrombus
characterization where oxygenation is an unknown quantity.
Second, we trained a deep convolutional neural network to predict
histological RBC content from ex vivo MR images of ischemic stroke thrombi.
We demonstrate that a convolutional neural network is capable of RBC
content prediction with 66% accuracy and 8% mean absolute error when
trained on a limited thrombus dataset, and that prediction accuracy can be
improved to up to 74% through data augmentation.
Finally, we used a random forest classifier to predict clinical stroke etiology
using the same ex vivo thrombus MR image dataset. Here, quantitative
thrombus R2*, QSM and FF image texture features were used to train the
classifier, and we demonstrate that this method is capable of accurate
etiology prediction from thrombus texture information alone (accuracy = 67%,
area under the curve (AUC) = 0.68), but that when combined with patient
clinical data the performance of the classifier improves dramatically to an
accuracy and AUC of 93% and 0.89, respectively.
Together, the works presented in this thesis offer extensive ex vivo evidence
that quantitative MR imaging is capable of effective stroke thrombus etiology
characterization. Such a technique could enable clinical consideration of
thrombus composition and bolster stroke etiology determination, thereby
improving the management and care of acute ischemic stroke patients.

Keywords
Magnetic Resonance Imaging, Stroke, Thrombus, Quantitative Imaging,
Machine Learning, Deep Learning
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Lay Summary
Stroke is a devastating and prevalent disease. One of the largest challenges
in stroke treatment is rapidly determining the cause, or etiology, of the stroke
so that the risk recurrence can be mitigated. Currently, diagnostic tests for
etiology determination are slow and unreliable, and in about one third of
patients etiology is never determined. In ischemic stroke, thrombus
composition, specifically red blood cell (RBC) content, has been shown
through histological analysis to be predictive of stroke etiology. However,
histological analysis is too slow to be performed in an acute clinical setting;
non-invasive imaging techniques capable of rapid stroke etiology prediction
hold immediate value in stroke care. Currently existing techniques use
qualitative metrics and have produced underwhelming performance; the goal
of this thesis was to develop a quantitative MR imaging method capable of
accurate acute ischemic stroke etiology prediction.
In this thesis, I use the quantitative MR parameters R2*, quantitative
susceptibility mapping (QSM) and fat fraction (FF) to characterize stroke
thrombi. First, I showed that R2* and QSM can be used to derive a
relationship with RBC content in blood clots in vitro. Following this, I applied
deep learning to quantitative ex vivo thrombus MR images to predict
histological thrombus RBC content. Finally, I used machine learning applied
to texture features extracted from thrombus R2*, QSM and FF maps to
predict stroke etiology using a random forest classifier. Separate models were
built using patient clinical data and the combined set of thrombus texture
and clinical data features. I found that the model built from imaging
information alone was able to predict stroke etiology with comparable
accuracy to previous qualitative models, but that when combined with
patient clinical data the model’s performance far exceeded that of previously
derived predictors and generated highly accurate predictions of stroke
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etiology in an independent test set. The works presented in this thesis offer
extensive ex vivo evidence that quantitative MR imaging is capable of
effective stroke thrombus etiology characterization. If implemented clinically,
such a technique could enable consideration of thrombus composition and
bolster stroke etiology determination, thereby improving management and
care of acute ischemic stroke patients.
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CHAPTER 1

General Introduction

1.1 Motivation and overview
Stroke represents one of the most prevalent and devastating diseases across
the world. In 2013, stroke was the second most common cause of death and
third most common cause of disability worldwide.1 In Canada, one stroke is
said to occur every 10 minutes, and collectively stroke is responsible for an
economic burden of over $3.6 billion in direct costs annually.2 While recent
years have seen the incidence, mortality and disability burden of stroke
decline,3 the number of people who are affected by stroke in any form (deaths,
survivors, and those who remain disabled) is increasing.1
Patients who have survived their first stroke are over 10 times more likely to
have a second within 12 months compared to those with no stroke history,4,5
and these secondary strokes are more likely to be fatal or disabling than the
first.6 With the number of stroke survivors in Canada expected to increase by
1.5 to 2 times between 2013 and 2038,7 there is a growing population of
individuals with heightened stroke risk who require prophylactic therapy to
minimize their risk of stroke recurrence. The optimal therapy for limiting
recurrence is specific to the underlying etiology (cause) of the primary stroke,
however etiology may takes weeks to determine, and even following extensive
clinical testing remains unknown in as much as 35% of cases.8
Medical imaging, through x-ray, ultrasound, computed tomography (CT) and
magnetic resonance (MR) imaging, serves a vital role within acute stroke
care. CT and MR imaging are currently the only techniques available to
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identify whether a stroke is ischemic or hemorrhagic in nature, a critical
disease characteristic which determines the course of stroke treatment.9
However, no attempt is currently made to use imaging techniques to deduce
stroke etiology beyond the use of x-ray angiography and echocardiography to
search for signs of atherosclerotic stenosis and arrhythmia, respectively;
these have proven to be inconsistent and unreliable indicators. This approach
fails to take advantage of all the information available from acute imaging,
and in ischemic stroke in particular, ignores the information available from
within the thrombus (blood clot) itself. Evidence is mounting to suggest that
thrombus composition may be indicative of underlying stroke etiology.8,10,11
Presently, the only method to assess thrombus composition is histological
analysis, but this can only be completed in cases where a thrombus has been
physically retrieved from the patient during treatment. The benefit of an
imaging method capable of non-invasively identifying thrombus composition
is immeasurable, and there remains ample room for improvement amongst
current experimental imaging techniques.
Admittedly, because stroke care is extremely time-sensitive, access to
advanced imaging scanners, particularly for MR imaging, is a challenge for
many centres and limits the ability to add new imaging techniques to stroke
protocols. However, the increasing accessibility of MR and CT scanners,
combined with recent recommendations from the American Heart Association
that stroke patients presenting within 6 – 24 hours of symptom onset receive
advanced imaging (MR or CT) to guide therapy,12 means that the number of
patients for which advanced imaging can be completed is only increasing.
This thesis describes the development and validation of novel MR imaging
analysis techniques aimed at quantitatively predicting the composition and
etiology of acute ischemic stroke thrombi. The work presented herein first
demonstrates the sensitivity of the relevant quantitative MR imaging
parameters to RBC content in a set of blood clots prepared in vitro (Chapter
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2), followed by an evaluation of composition inference (Chapter 3) and
etiology prediction (Chapter 4) using deep learning and machine learning,
respectively, applied to quantitative MR images of retrieved acute stroke
thrombi ex vivo. This introductory chapter provides a comprehensive
overview to motivate the work presented in the following chapters, beginning
with a description of the pathophysiologic mechanisms of stroke (1.2),
followed by the evolution of acute stroke care (1.3), current stroke etiology
determination techniques and their associated limitations (1.4), histological
relationships between thrombus composition and etiology (1.5), previously
developed imaging techniques for thrombus composition and etiology
prediction (1.6), modern machine and deep learning image analysis
techniques and their potential for improved thrombus characterization (1.7),
and finally the hypothesis and objectives of this thesis (1.8).

1.2 Stroke mechanisms and treatment
A stroke occurs when brain cells are damaged due to improper blood flow,
and may occur due to lack of blood from vessel blockage (ischemic) or
compression from an internal bleed (hemorrhagic). For the former, treatment
consists of restoration of blood flow to the affected tissue. The derived benefit
from reperfusion depends strongly on the length of time the brain has faced
oxygen deprivation. Assessment of the affected tissue’s viability and
prediction of the brain’s response to reperfusion is the most important task
faced by stroke interventionalists treating ischemic stroke.
A stroke occurs when brain tissue is injured by either a deprivation of
oxygenated blood supply or hydrostatic pressure from an internal bleed, to an
extent and duration upon which neurological symptoms of impairment begin
to appear. Lack of oxygen results in neuronal cell energy metabolism
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disruption leading to ion channel failure, sodium, chloride and then water
influx, while internal bleeding results in the mechanical disruption and
deformation

of

cells,

mitochondrial

dysfunction

and

membrane

depolarisation.13,14 Both mechanisms result in cell swelling (cytotoxic edema)
and, eventually, to irreversible cell death. Symptoms of stroke vary widely
depending on the region facing injury, but most commonly manifest as acute
one-sided weakness (hemiparesis), facial droop, difficulty understanding and
formulating speech (aphasia), unclear speech (dysarthria), visual field
deficits, headaches and/or lack of muscle coordination (ataxia).15 Strokes
occurring as a result of hypoxia are referred to as ischemic while those due to
internal bleeding are referred to as hemorrhagic. Ischemic strokes, the focus
of this thesis, represent approximately 80% of all strokes,16 and are most
commonly caused by thrombi which have embolized from a downstream
artery and were halted within the narrowing cerebral vessels, disrupting
blood flow. A photograph of a retrieved ischemic stroke thrombus is shown in
Figure 1-1. Less commonly, thrombi may form in situ directly within cerebral
arteries (lacunar stroke),17 or, less commonly still, stroke may be caused be
the embolization of materials other than thrombus, including fat, calcium,
air, infected (septic) tissue or tumour (usually myxoma).18
In all cases, the treatment for ischemic stroke is reperfusion therapy;
restoration of blood flow to the ischemic areas. In principle, complete
reperfusion of affected tissue can lead to the eradication of symptoms and
near-instant recovery, if all affected tissue is still viable. In practice, complete
reperfusion is rarely achieved, may serve no benefit to tissue which has
already been irreversibly infarcted, and may actually cause damage to
surrounding viable tissue through hemorrhage of areas reperfused with a
blood brain barrier disrupted by ischemia.19 Failure to achieve reperfusion in
viable tissue however can lead to permanent disability or death, and while
the human brain is capable of recovery through the rewiring of neurons to a
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phenomenal degree, a process known as neuroplasticity, a return to prestroke capability rarely occurs.20 Determination of the amount of salvageable
tissue, and the risks associated with treatment, is therefore the critical task
for stroke interventionalists treating ischemic stroke. Methods for achieving
reperfusion have thus developed in tandem with strategies to identify the
patients most likely to derive benefit.

Figure 1-1: Gross photograph of a thrombus retrieved from an acute ischemic
stroke patient. Shown below it is the stent retriever used to remove the
thrombus from the cerebral vessels as a part of endovascular therapy, which
is discussed in section 1.3.

1.3 Evolution of acute ischemic stroke care and the role of
imaging
Our understanding of stroke and its optimal care continues to evolve.
Reperfusion is currently the only treatment and two clinically approved
techniques to achieve this exist today: thrombus lysis by recombinant tissue
plasminogen activator and extraction by endovascular therapy. Each has
seen its usefulness and impact expand since it was first approved, and in
particular, the recently widened treatment time window for endovascular
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therapy opens the door for increased involvement of advanced imaging
techniques within acute stroke care.
The first recorded description of stroke came in the 4th century BCE from
Hippocrates, who termed a set of symptoms that included sudden onset
paralysis, loss of consciousness and death as “apoplexy,” meaning “struck
down violently.”21 Since then, our understanding of the causes and
mechanisms of stroke have grown enormously, and yet only recently has
modern medicine been capable of direct treatment. Up until the 1990’s,
stroke treatment consisted largely of supportive care and the prevention of
complications.21 Following the results of a 1995 National Institute of
Neurological Disorders and Stroke recombinant tissue plasminogen activator
(rtPA) study,22 the Food and Drug Administration approved the use of
intravenous rtPA for ischemic stroke patients within 3 hours of symptom
onset in 1996.23 rtPA is a synthetic version of the naturally occurring human
clot-dissolving protein, tissue plasminogen activator, and was initially
indicated for all ischemic stroke patients under 3 hours post-onset lacking
contraindications

to

the

drug.

Further

studies

and

clinical

trials

demonstrated that rtPA could be beneficial for patients up to 4.5 hours after
onset if those presenting with severe infarction, and therefore low tissue
viability, as determined by non-contrast CT were excluded.24,25
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Figure 1-2: Non-contrast CT of an acute ischemic stroke patient showing
signs of infarction by hypoattenuation of the right lentiform nucleus (arrows).
Subtle hypoattenuation present in the acute stroke image (left) acquired 22
minutes after stroke onset progresses to more distinct hypoattenuation at 1
(middle) and 7 (right) days after stroke onset. Figure from Von Kummer et
al., reproduced with permission.26
CT is capable of detecting severe edema associated with infarction through
hypoattenuation within brain parenchyma, as shown in Figure 1-2. The
number and extent of hypointense lesions is associated with risk of
hemorrhagic transform following rtPA administration.27 However, noncontrast CT possesses a relatively poor sensitivity (~65%) for detecting acute
stroke lesions,26 and lacks the ability to identify tissue at risk of infarction
but not yet beyond the threshold of irreversible damage. Hypoperfused tissue
that is salvageable but will proceed to infarction if left untreated is referred
to as the stroke “penumbra,” while ischemic tissue that has already past the
point of irreversible damage and will infarct is deemed the “core.”28 In
conjunction with the rising prominence of rtPA treatment came MR studies
demonstrating the potential for diffusion-weighted imaging (DWI) to
visualize the infarct core along with perfusion-weighted imaging (PWI) to
show the penumbra.29,30 A mismatch between DWI and PWI lesions indicates
the presence of vulnerable penumbral tissue that will proceed to infarction if
reperfusion is not achieved (Figure 1-3). A non-placebo-controlled study
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(DEFUSE) demonstrated promise that DWI and PWI could be used to
identify patients who would respond positively to rtPA for up to 6 hours after
onset, showing that patients with mismatched DWI/PWI lesions responded
better than those with similar lesion sizes at presentation.31 However, a later
randomized controlled trial (EPITHET) into the use of DWI/PWI failed to
show a difference in benefit between patients given rtPA with and without a
mismatch.32 As a consequence, advanced imaging selection for rtPA
administration was never widely adopted into the clinic and the 2018
Canadian stroke guidelines recommend no input from imaging for the
decision beyond examining for hemorrhage and infarction severity on CT.33

Figure 1-3: Diffusion-perfusion MR images of an acute ischemic stroke
patient showing mismatch in size between hyperintense lesions in the right
caudate nucleus on DWI (left) and PWI (middle) images acquired 4.5 hours
after stroke onset. A T2-weighted image (right) acquired 7 days after onset
shows a final ischemic lesion that has expanded beyond the DWI lesion
within the region of the perfusion abnormality. Figure from Baird et al.,
reproduced with permission.30
However, in recent years the use of imaging to illuminate penumbral and
core tissue has seen a resurgence with the advent of endovascular therapy,
the use of an inserted stent retriever (mechanical thrombectomy) or aspirator
to physically remove the occluding thrombus. A 2012 prospective study
showed benefit in the use of DWI/PWI for selection of patients receiving

9
endovascular therapy within 12 hours of onset.34 Contemporaneously, CT
perfusion (CTP) imaging was gaining prominence as a tool for penumbral
stroke imaging, and was shown to provide a comparable assessment of
ischemic core and penumbra as DWI and PWI.35 A 2014 randomized clinical
trial (EXTEND-IA) demonstrated benefit for endovascular therapy in
patients stratified by CTP-based perfusion mismatch assessments within 8
hours of symptom onset.36 By the mid-2010’s, the utility of advanced (MR or
CT) imaging for selecting patients suitable for endovascular therapy was well
documented, but given the relatively short accepted time window for which
patients could be treated (6 – 8 hours in most centres), only a fraction of
stroke patients were eligible and in Canada advanced imaging selection was
not formally recommended unless it could be done without any delay of
treatment administration.37 Recently, two randomized, controlled trials
(DAWN, DEFUSE 3) demonstrated clear evidence in favour of using
advanced, perfusion-based imaging (MR or CTP) to identify patients most
likely to benefit from endovascular therapy, and notably this was
demonstrated in patients at up to 24 hours after stroke onset.38,39 Following
the release of these trials, stroke guidelines were updated and today
advanced imaging is recommended for ischemic stroke patients arriving
between 6 – 24 hours after symptom onset to select patients likely to benefit
from therapy; stroke centres are expected to see a significant increase in the
number of patients eligible for advanced imaging and endovascular therapy
subsequent to the implementation of these guidelines.9 Such an increase also
creates opportunity for adoption of novel imaging acquisitions, which expand
the information available to clinicians during acute stroke treatment. Beyond
selecting patients appropriate for acute treatment, imaging also offers
potential for improving patient care during their recovery; namely in
identifying the underlying cause of the primary stroke so that the risk of
recurrence can be mitigated.
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1.4 Stroke etiology and clinical diagnosis
A number of potential mechanisms can be responsible for ischemic stroke.
The need to identify the underlying cause, or etiology, of a stroke is critical
given the elevated risk of recurrence after primary stroke as the most
effective risk-mitigating therapy differs between etiologies. In particular,
cardioembolic and large artery atherosclerotic stroke are the most common
etiologies and require different antithrombotic drugs to optimally limit their
chance of recurrence; cardioembolic strokes are most often caused by
arrhythmias, which can be challenging to detect within the post-stroke
window of elevated secondary stroke risk.
Stroke is a unique disease in that the risk of recurrence is vastly increased
after an initial stroke has occurred; within one year the risk of recurrence is
approximately 13%, over 10 times the risk in the general population.40
Compounding this is the unfortunate fact that secondary strokes are typically
more devastating than the first. Accordingly, identifying the underlying
cause, or etiology, of a stroke so that the patient may be treated to optimally
mitigate the risk of recurrence is a critical component of stroke care. There
are myriad different causes, known as subtypes, of ischemic stroke and these
will be detailed in the following section before current strategies for etiology
determination, and their associated weaknesses, are discussed.

1.4.1 Subtypes of acute ischemic stroke
The Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification
system,41 developed in the 1990’s, remains the most widely used system to
categorize stroke subtype in clinics today, largely due to its simplicity relative
to later proposed schemes.42 TOAST stratifies ischemic stroke into one of 5
subtypes: large-artery atherosclerosis (LAA), cardioembolism (CE), small-
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vessel occlusion (SVO), stroke of other determined etiology and stroke of
undetermined etiology.
LAA is diagnosed in approximately 25% of all ischemic strokes,43 and occurs
subsequent to an immunoinflammatory reaction to circulating blood
cholesterol resulting in atherosclerotic plaque formation within the vessel
wall of a major feeding artery to the brain (typically the internal carotid
artery).44 The growing plaque expands into the vessel lumen and often, but
not always, ruptures prior to inducing thrombosis on its surface; the nascent
thrombus eventually embolizes to the intracranial arteries.45 Almost
everyone develops detectable atherosclerosis within intracranial vessels as
they age,46 and the risk of LAA stroke has been correlated to its severity.47
CE is diagnosed in between 20 to 40% of ischemic strokes and is resultant
from a vast number of potential mechanisms, the original TOAST paper lists
over 20 possible sources,41 but most commonly occurs from complications of
atrial fibrillation. Atrial fibrillation is a sporadic, often asymptomatic
arrhythmia of the heart that causes blood to flow poorly and stagnate within
its chambers, eventually leading to thrombus formation. When no
concomitant valvular disease is present (70-96% of AF cases),48 90% of AFinduced thrombi form within the left atrial appendage,49 where they can sit
for weeks or perhaps months at a time prior to embolization.50 AF is present
in only 1% of adults (9% of those 80 and older), but entails a 5-fold overall
increase in stroke risk compared to those in normal sinus rhythm.51
SVO, also known as lacunar stroke, is diagnosed in approximately 15% of
ischemic strokes and is defined as a stroke that occurs within the subcortical
vessels of the brain. SVO occurs either through lipohyalinosis, a fibrotic
vessel wall thickening, or intracranial atherosclerosis through a process
originally thought to be distinct from the cervicocranial atherosclerosis
responsible for LAA,52 being associated specifically with vascular conditions
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including diabetes and hypertension.41 However, more recent work has
demonstrated no difference in the risk factor profiles between SVO stroke
patients and those of other types.53 SVO strokes are comparably less severe
than those from LAA and CE,54 as they necessarily involve smaller vessels
with less overall impact on cerebral perfusion, and will not be discussed
further in this thesis.
Strokes of other determined etiology represent approximately 5% of ischemic
stroke cases and consist of the miscellaneous, uncommon causes of stroke
including dissection, other nonatheroslerotic vasculopathies, hypercoagulable
states and hematologic disorders.41
Strokes of undetermined etiology account for approximately 35% of ischemic
strokes, though this number varies widely between stroke sites due to
differences in clinical practice and resources. This subtype includes both
strokes whose cause could not be identified following clinical evaluation, and
those in which two or more potential, conflicting causes were identified.
There is evidence to suggest that the majority of undetermined strokes are
CE in origin, following the missed diagnosis of arrythmia.8

1.4.2 Clinical determination of etiology
The current clinical approach for identifying stroke etiology follows from that
prescribed by the original TOAST criteria; LAA is considered if significant
stenosis (>50%) can be found in any major ipsilateral carotid artery, in
absence of the 20+ risk factors that indicate CE, and vice versa.41 Stenosis is
typically evaluated through an x-ray angiogram, while AF, if not previously
diagnosed,

is

searched

for

through

echocardiographic

and

electrocardiographic (ECG) monitoring during a patient’s hospital stay prior
to long-term observation at home with an external ECG monitor for at least 2
weeks if necessary.55 Additional causes of embolic stroke are identified
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through a wide variety of means, including ultrasound imaging, laboratory
blood tests and examining clinical history. These etiologies vary in their
difficulty to identify, but are uncommon and their clinical impact is relatively
minor compared to that of the LAA and CE subtypes.

1.4.3 Weaknesses of the current paradigm
Following an ischemic stroke, antiplatelet drugs are routinely given to reduce
the risk of stroke recurrence. However, for CE strokes caused by AF,
antiplatelets are only moderately effective compared to anticoagulant
drugs56,57 but these can only be given after a diagnosis of AF is made.55
Because AF can be paroxysmal, it is often not detected during a patients
short term hospital stay and patients are sent home to complete long-term
cardiac monitoring with an ineffective therapy, thereby unnecessarily
heightening their risk of stroke recurrence. Beyond this, in as many as 1 in 3
patients with AF the arrhythmia is not detected even after 30 days of athome monitoring.58
For LAA strokes, the arbitrary cutoff of >50% stenosis for diagnosis has been
criticized as it incorrectly classifies those with less than 50% as a stroke of
undetermined etiology, and may confound other classifications such as CE if
a stenosis is found but is asymptomatic and unrelated to the stroke.59 One
study has found significant (>50%) stenosis in nearly 25% of ischemic stroke
patients with AF; in these cases the stroke would also be classified stroke of
undetermined etiology, due to multiple identified causes.60
Overall, the methods used by clinicians today to deduce etiology are
insensitive and unspecific; decisive criteria are neither definitive nor
mutually exclusive and the origin of many strokes is never determined. As
such, there is ample room for clinicians to consider additional information
that may help inform their etiological diagnosis. A vast amount of
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information contained within stroke thrombi, the underlying cause of
ischemic stroke itself, is available to be leveraged but currently remains
ignored within clinical practice.

1.5 Thrombus composition and its relationship to stroke
etiology
There remains significant room for improvement in the determination of
ischemic stroke etiology, and an area that has thus far being inadequately
explored is the information present within the thrombus itself; its
composition. An accumulation of histological studies have demonstrated a
link between thrombus RBC content and stroke subtype. Knowledge of
thrombus RBC content has the potential to guide and improve acute stroke
care, but histological analysis is not possible to perform in the many cases
where a thrombus is not retrieved. Rapid, non-invasive assessment through
medical imaging is required for thrombus composition to be considered within
acute stroke care.
Four major components constitute the vast majority of all thrombi: red blood
cells (RBCs), fibrin, platelets, and white blood cells (WBCs). A schematic
diagram depicting these components within stroke thrombi is shown in
Figure 1-4. Thrombus formation is initiated by thrombin generation through
either the collagen- (intrinsic) or tissue factor- (extrinsic) dependent
pathways, which cause the development of fibrin strands from circulating
fibrinogen segments as well as the activation of platelets that bind to and
connect fibrin strands together to form a mesh-like structure.61 Platelet
activation causes the recruitment of WBCs into the nascent thrombus,
initiating

an immunoinflammatory response which accompanies and

regulates thrombus formation and dissolution.62 RBCs are incorporated into
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thrombi via passive entrapment in the fibrin mesh, and the scope of their
influence over thrombosis is still not fully understood.63 Occasionally,
additional components present at the site of thrombus formation, such as
lipid in the form of cholesterol crystals and calcium hydroxyapatite from
intravascular calcifications, may be incorporated into a thrombus as well.

Figure 1-4: Schematic drawing of the typical components constituting stroke
thrombi. Activated platelets connect fibrin strands to form a webbing which
encapsulates RBCs, WBCs, and holds the thrombus together. Isolated
pockets of RBCs tend to form within platelet/fibrin-rich regions with WBCs
on the border between them.64
The relative proportion of each of these components varies widely between
thrombi, as they are influenced by the specific conditions under which
thrombosis occurred. Variability in blood flow within stenotic vessels has
been linked to heterogeneous deposition of platelets, for example.65
Consequently, the composition of an embolic thrombus may be indicative of
its source. Numerous studies have attempted to derive relationships between
thrombus composition and stroke etiology; to do so histological analysis is
used.
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Histological examination involves the dehydration, embedding, slicing and
staining of tissue samples for examination under a microscope. It provides
the gold-standard assessment of tissue composition through microscopic
resolution images of slides, which are stained to illuminate a wide array of
cellular and non-cellular components. Hematoxylin and eosin (H&E) is the
most common stain used for thrombus histological analysis; it uniquely
identifies RBC and WBC components but cannot distinguish between fibrin
and platelets. These stain images can be segmented to quantitatively assess
the proportion of all components within a thrombus section. An example
thrombus H&E stain image and segmentation is shown in Figure 1-5.

Figure 1-5: Example thrombus H&E section at low (A) and high (B)
magnification with RBCs in red, fibrin/platelets in pink and WBCs in dark
blue. An example segmentation output used to quantify thrombus
composition is shown in (C). The typical thrombus has a composition of
approximately 30, 60 and 10% RBCs, fibrin/platelets and WBCs,
respectively.10 Note the heterogeneous distribution of components, with
distinct deposits of RBCs and fibrin/platelets arranged throughout the
thrombus.
With the advent of endovascular therapy greatly expanding the number of
thrombi available for histological analysis, recent years have seen a dramatic
increase in the number of studies examining the clinical implications of
thrombus composition. A summary of the results of all current histological
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studies examining the relationship between thrombus composition and stroke
etiology are shown in the table below:
Table 1-1: Studies assessing the relationship between ischemic stroke
etiology and histological composition of thrombi retrieved by endovascular
therapy
Primary
author
Marder66

Year
2006

No of
patients
25

Liebeskind67

2011

50

Sato68

2012

17†

BoekhBehrens69

2014

34

Niesten70

2014

22

Sallustio71

2014

28

Kim72

2015

37

Simons73

2015

40

Ahn11

2016

36

BoeckhBehrens8
Sporns10

2016

137

2017

187

Maekawa74

2018

43

Fitzgerald75

2019

105

Analysis
method
Qualitative
categorization
Semiautomated
quantification
Semiautomated
quantification
Semiautomated
quantification

Differences between
CE – LAA thrombi*
None

Visual
quantification
Qualitative
categorization
Semiautomated
quantification
Qualitative
categorization
Semiautomated
quantification
Semiautomated
quantification
Semiautomated
quantification
Semiautomated
quantification
Semiautomated
quantification

LAA: ↑RBC

None
CE: ↑RBC; LAA: ↑fibrin
CE: ↑WBC

None
CE: ↑RBC; LAA: ↑fibrin
None
CE: ↑fibrin; LAA: ↑RBC
CE: ↑fibrin/platelet,‡
↑WBC; LAA: ↑RBC
CE: ↑fibrin/platelet,‡
↑WBC; LAA: ↑RBC
CE: ↑fibrin; LAA: ↑RBC
LAA: ↑platelet

*Significant difference in thrombus area (%) between CE and LAA subtypes
(p < 0.05); †Thrombi collected at autopsy; ‡Fibrin and platelets not
differentiated in examination. CE, cardioembolism; LAA, large artery
atherosclerosis; RBC, red blood cells; WBC, white blood cells.
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Despite the lack of consensus, methodological differences in the approach of
these histological studies are instructive. Of note is that the majority (3/4) of
studies finding no difference in thrombus composition between subtypes
performed only qualitative classification of thrombi (categorized into “fibrin
enriched,” “serpentine,” “erythrocytic”, “layered” etc.), rather than employing
some form of automated quantification of each component’s proportion.
Among those that did perform quantitative assessment, the trends of early
studies indicating CE thrombi having a higher proportion of RBCs directly
oppose those of more recent studies indicating a higher proportion of fibrin,
and less RBCs, in that same subtype. This shift could be explained by
improvement in endovascular therapy devices and general operator
experience increasing the proportion of thrombi retrieved as the therapy
became more widespread. Early studies also tended to have smaller sample
sizes than more recent ones. The consensus within recent studies suggests
that a lower RBC and higher fibrin proportion is expected in thrombi caused
by CE compared to those caused by LAA. It is worth noting that all studies in
general found a trend of higher RBC levels in thrombi with low fibrin
content, and vice-verse, indicating that these components are inversely
related and are the principle sources of variation within stroke thrombus
composition.
Beyond the primary thrombus components, a few studies have identified the
presence of lipid45,76 or calcium77,78 within thrombi and drawn relations to
etiology. Lipid was found only in thrombi derived from LAA, while calcium
was found only in thrombi derived from LAA or following an invasive cardiac
procedure (suggesting disruption of a calcified cardiac valve), indicating that
the presence of either of these components may be directly predictive of LAA
stroke etiology in the absence of a preceding surgical procedure.
There is strong evidence to support that thrombus composition may be a
useful property for determining stroke etiology. However, histological
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analysis is an involved process and can only be completed for patients in
which a thrombus is retrieved, making it inappropriate for wide use within
clinical care. Only 30-40% of ischemic stroke patients present with an
occlusion large enough for endovascular therapy to be feasible, and just 25%
of these patients are ultimately eligible for the therapy.79,80 Within these
eligible patients 80% will have thrombi retrieved, meaning only 7% of
ischemic stroke patients overall have thrombi available for histological
study.81 Medical imaging offers the potential to noninvasively infer thrombus
properties regardless of retrievability including but not limited to thrombus
composition, however it presents its own unique set of challenges. The
following section examines past attempts to leverage medical imaging to
predict ischemic stroke thrombus composition and etiology, as well as the
limitations associated with each technique.

1.6 Imaging inference of thrombus composition and
etiology
Both MR and CT imaging are capable of assessing thrombus RBC content via
their sensitivity to iron within the hemoglobin molecule. A number of
previous studies have used qualitative MR or CT imaging signs to
characterize thrombi and have demonstrated an association with RBC
content. However, these signs have collectively proven unable to predict
stroke etiology. With MR imaging, sensitivity to RBC oxygenation may
confound qualitative predictions; quantitative MR approaches including R2*
and quantitative susceptibility mapping may provide a basis to assess RBC
content independent of oxygenation. However, typical statistical measures
derived from quantitative thrombus images may not be sufficient for etiology

20

prediction, and more advanced techniques that account for intra-thrombus
heterogeneity may be required.
Coincident with stroke thrombus histological studies, medical imaging
studies have been performed examining the relationship between thrombus
imaging properties, composition and etiology. Both MR and CT imaging are
sensitive to the iron atoms inside RBC hemoglobin, allowing non-invasive
interrogation of RBC content.82,83 Qualitative and quantitative imaging
characterization techniques have been developed and are described in the
following subsections.

1.6.1 Qualitative thrombus MR characterization
In MR imaging, the hemoglobin iron atom possesses a high magnetic
susceptibility which causes local field inhomogeneity, spin dephasing and
ultimately signal loss. Importantly, this effect occurs only when hemoglobin
is not bound to oxygen; this increases MR sensitivity to stroke thrombi
relative to circulating blood, as tissue ischemia leads to reduced oxygen
content in thrombi relative to oxygenated arterial blood.82 The presentation of
a dark signal void resultant from deoxyhemoglobin within a stroke thrombus
on gradient echo (GRE) imaging is referred to as a susceptibility vessel sign
(SVS) (Figure 1-6).84
In non-contrast CT imaging, iron’s high electron density leads to elevated
photon attenuation relative to tissue, resulting in higher signal. CT signal
intensity is measured in Hounsfield units (HU), and RBC content has been
correlated to CT HU values in blood clots in vitro.85 However, unlike MR
imaging, CT’s sensitivity to hemoglobin is independent of RBC oxygenation
state, and it is therefore equally sensitive to iron inside thrombi as in
circulating blood, resulting in a lower relative sensitivity to stroke thrombi
than that of MR.86 The presence of bright signal inside a stroke thrombus on
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non-contrast CT imaging is referred to as a hyperdense artery sign (HDAS)
(Figure 1-6).87 Numerous studies have demonstrated a relationship between
the presence of both the SVS and HDAS and stroke thrombus RBC
content.67,88,89

Figure 1-6: Neurological MR (left) and CT (right) images of stroke patients
demonstrating qualitative thrombus imaging signs; SVS and HDAS,
respectively. Figures from Liebeskind et al., reproduced with permission.67
A number of studies have employed these qualitative imaging signs to search
for a relationship with stroke etiology.90-92 While certain studies have derived
significant associations, with most linking positive imaging signs to CE
stroke, a recent meta-analysis of these studies found no statistically
significant relationship overall between either SVS or HDAS and stroke
etiology.93 These qualitative imaging assessments are limited by their ability
to provide only binary information, and have demonstrated issues with intraobserver and intra-scanner variability.94 Quantitative MR imaging methods
have been investigated as a means to provide more advanced imaging
characterization of stroke thrombi, while reducing reliance on individual
interpretation. The quantitative MR metrics employed for thrombus
characterization in this thesis include effective transverse relaxation time
(R2*) and quantitative susceptibility mapping (QSM).
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1.6.2 Effective transverse relaxation time (R2*)
Disruption of the main MR magnetic field (B0) homogeneity by RBC
deoxyhemoglobin leads to transverse signal dephasing and signal loss. This
effect is quantifiable by measurement of the rate of signal loss in a signal
decay curve, a plot of voxel magnitude values obtained across multiple echo
times. In GRE imaging the signal decay rate corresponds inversely to the
effective transverse relaxation time, known as R2* (=1/T2*), and is commonly
derived through an exponential fit of the signal decay curve (Figure 1-7).

Figure 1-7: Example signal decay curve with an exponential curve fit. Higher
R2* values correspond to more rapidly decaying signal.
While straightforward to perform, the exponential fit technique can lead to
erroneous R2* values in voxels with very rapid signal decay, and the observed
signal evolution can be influenced by several other factors including
underlying B0 inhomogeneity and the presence of fat tissue. Because of this,
more advanced signal processing methods have been developed which model
R2*, B0 inhomogeneity and fat fraction (FF) simultaneously, though accurate
FF mapping was the primary focus of these techniques rather than R2*.95,96
The B0-NICE method, developed in the Drangova lab, also models R2*, B0
field and FF and was designed to output accurate measurements of all
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three.97 B0-NICE uses a non-iterative lookup table approach to R2* mapping
which is less susceptible to underestimation of R2* values in voxels with rapid
signal loss, and is the algorithm used to quantify thrombus R2* in this thesis.
The B0-NICE FF maps were additionally used to assess thrombus lipid
content.

1.6.3 Quantitative susceptibility mapping
The mechanism through which the deoxyhemoglobin iron atom disrupts the
B0 field is through a bending of its magnetic field force lines, changing the
strength of the field inside and around it (Figure 1-8). All materials interact
with and alter magnetic field lines to some extent; the parameter that
quantifies the degree of this alteration is known as magnetic susceptibility.
Materials which increase the strength of the local field are known as
paramagnetic while those that decrease it are known as diamagnetic. Water,
the main component of human tissue, has a diamagnetic susceptibility
of -9.04 ppm, while RBC deoxyhemoglobin is paramagnetic relative to water
with a magnetic susceptibility of -5.61 ppm, commonly written as a
+3.43 ppm relative shift.98 Oxyhemoglobin has a comparatively negligible -0.1
ppm diamagnetic shift relative to water.

Figure 1-8: A uniform magnetic field in the presence and absence of magnetic
material. Paramagnetic materials have a positive magnetic susceptibility and
attract magnetic lines of force, while diamagnetic materials have a negative
susceptibility and repel them.
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A material’s magnetic susceptibility directly influences the strength of the
magnetic field it observes in addition to those of the atoms surrounding it.
While high intravoxel susceptibility variation leads to the signal loss
quantifiable by R2* mapping, direct estimation of a material’s magnetic
susceptibility is also possible through a technique known as quantitative
susceptibility mapping. Background field contributions to local phase are first
removed to produce a local frequency shift map which is converted to a QSM
map through an inversion process involving deconvolution of the dipole
kernel. This inversion process is ill-posed however in that certain regions of
the dipole kernel are undefined, meaning there are an infinite number of
potential inversion solutions. QSM algorithms overcome this by incorporating
prior information into the inversion; strategies differ across the multitude of
QSM algorithms that have been developed though enforcing spatial
smoothness in the estimated QSM map through regularization is the typical
added condition.99,100 One of the most widely used QSM algorithms, known as
morphology enabled dipole inversion (MEDI), explicitly matches spatial
gradients within input magnitude images to gradients in the estimated QSM
map, penalizing the formation of streaking artifact edges that plague many
QSM reconstructions.101 MEDI is the QSM algorithm used to analyze
thrombus magnetic susceptibility in this thesis.

1.6.4 Quantitative thrombus MR characterization
Direct assessment of R2* and QSM from multi-echo GRE acquisitions has
been previously performed on prepared blood clots in vitro and demonstrated
sensitivity to both blood clot RBC content and oxygenation, as expected
(example shown in Figure 1-9).102,103 However, no study has quantified these
MR values on blood clots of simultaneously varied composition and
oxygenation, meaning that any translation of the derived relationships to
stroke thrombi will be confounded by the codependence of R2* and QSM on
both factors. The second chapter of this thesis describes an in vitro study
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designed to bridge this gap by deriving a quantitative relationship between
blood clot R2* and QSM that can be used to predict clot RBC content
independent of oxygenation.

Figure 1-9: MR R2* (A) and QSM (B) maps of a phantom containing pairs of
deoxygenated blood clots prepared in vitro of 10-60% RBC content (yellow
label) with the remainder being composed of fibrin and platelets.
Assessment of the relationship between thrombus R2* and QSM and stroke
etiology remains limited. A single study has been completed that found no
significant difference in mean thrombus R2* between stroke etiologies.104
These inconclusive findings may be the result of small sample size (only 4
LAA thrombi studied), but may also be indicative of a more fundamental
weakness. Traditionally, quantitative imaging studies have used a single
imaging value or metric to represent an entire sample, while histological
studies

of

stroke

thrombi

have

consistently

shown

that

they

are

heterogeneously composed, with varied concentrations of their components
throughout their structure. Intrathrombus compositional heterogeneity is
observable with quantitative MR maps (Figure 1-10), at the scale of the
acquired image resolution, and as such more complex image analysis
methods sensitive to thrombus texture and morphology may allow more
effective characterization of stroke thrombi. The following section describes
artificial intelligence techniques, specifically machine and deep learning, and
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their potential

to extract

detailed intra-thrombus information from

quantitative MR images for improved prediction of stroke thrombus
composition and etiology.

Figure 1-10: Example thrombus (A) H&E histology slide (RBCs stain red;
fibrin/platelets stain pink) along with a corresponding slice of its (B) GRE
magnitude (TE = 31 ms), (C) R2* and (D) QSM maps. MR images are shown
in a coronal view, with the vertical scanning vial walls indicated with ► and
the thrombus outlined in cyan. Agar fills the space below the thrombus and
outside the vials. * indicates the RBC-rich body of the thrombus which has a
noticeably lower magnitude signal and higher R2* and QSM values than its
fibrin-rich tail.
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1.7 Artificial intelligence and potential for advanced
thrombus analysis
Artificial intelligence is a powerful tool that may be able to retrieve a greater
level of information from images of thrombi than traditional imaging metrics
can provide, specifically by interpreting intra-thrombus texture and
morphological information. Machine learning and deep learning are two
fields within artificial intelligence that have seen rapid growth in recent
years due to improved computing resources, as well as mounting proof of
utility within the medical imaging field. Machine learning makes explicit use
of imaging-derived texture features, while deep convolutional neural
networks are capable of deriving their own abstract features from raw images
as input. These complimentary techniques have each demonstrated capability
for providing valuable information related to stroke, but have seen very little,
if any, application towards the study of stroke thrombi. Evidence suggests
that they are powerful tools which may allow for more accurate
characterization of thrombi than that possible using traditional techniques.
Artificial intelligence describes the use of machines to perform tasks
normally considered to require human intelligence, such as visual perception,
decision-making, or problem solving. In the context of medical imaging,
artificial intelligence allows the extraction of rich sets of information from
quantitative imaging data beyond simple statistical measures such as mean,
variance, inter-quartile ratio etc., such as measures related to object texture
and morphology. As mentioned in the previous section, there is histological
justification for consideration of thrombus texture, given the heterogeneous
composition of most stroke thrombi. As thrombus composition is known to be
influenced by the environmental conditions under which they are formed,
interpretation of intra-thrombus information may yield deeper insight into
their history. Lines of Zahn, alternating wave-like laminations of platelets
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and fibrin interspersed between waves of RBCs, and outer shells of condensed
fibrin and aggregated platelets, have each been hypothesized to relate to
changes in blood flow and pressure as a thrombus forms.65,105 Subject to the
resolution limits of the input, artificial intelligence algorithms may be able to
interpret subtle thrombus texture or shape features which are informative of
its formation, and in doing so may allow both a finer characterization of
thrombus RBC content and better prediction of etiology. The following
sections describe in more detail two important forms of artificial intelligence,
machine and deep learning, and their respective properties suited for
thrombus analysis.

1.7.1 Machine learning
A subset of artificial intelligence, know as machine learning, refers to the use
of computer algorithms, which automatically improve through experience.
Typically, machine learning is applied in the context of supervised learning
for classification or regression problems, wherein a computer is trained on
labelled data with the aim of deriving a model, which can accurately predict a
desired class or value from new, unseen data. A vast array of machine
learning algorithms have been developed; a recent, exhaustive review
evaluated 179 algorithms within 17 different families (discriminant analysis,
Bayesian, neural networks, support vector machines, decision trees, rulebased classifiers, boosting, bagging, stacking, random forests, generalized
linear models, nearest neighbours, partial least squares and principal
component regression, logistic and multinomial regression, multiple adaptive
regression splines and other methods) for performing classification on 121
datasets.106 The review found the random forest classifier provided the best
general performance and this algorithm will be described in further detail in
this section, while neural networks will be described in the following section
as a segue into deep learning.
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Random forests consist of an ensemble of decision trees, which are tree-like
chains of ordered binary decision nodes designed to learn to deduce a desired
output value from input features derived from the dataset (e.g. age, colour,
price). Decision trees generate criteria at each node using the input features
to create a binary logic model; the computer derives the tree that most
accurately categorizes the training dataset to align with its desired outcome
variable. A random forest is created from multiple decision trees each trained
on a randomly sampled subset of the dataset. In doing so, random forests
overcome the tendency for single decision trees to overfit to its training
data.107 When forming predictions on unseen testing data, the result of each
decision tree is utilized to ‘vote’ on the predicted class or value; the random
forest outputs the most voted for class or average value for each observation
within the dataset (Figure 1-11).

Figure 1-11: Schematic diagram of the random forest classifier.
Regardless of the algorithm used, machine learning is dependent on the
quality of the input features for deriving a useful model capable of generating
accurate predictions. The ideal input dataset contains a rich feature set of
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multiple independent predictors of the desired outcome variable; in practice,
the independence and predictivity of each input feature is almost always
unknown and consequently large initial feature sets are desirable. From this
initial, unrefined feature set a process termed feature selection is performed
to identify the subset of features most predictive of the outcome variable.
Typically, some form of linear regression, wherein features are correlated to
each other and to the outcome variable to identify the features which are
most independent and predictive, is used.
Within the field of medical imaging, the extraction of quantitative features
from images is known as radiomics.108 Radiomics features can consist of
relatively simple, first-order statistical descriptors such intensity, size or
shape measurements, but these features don’t tend to provide information
that isn’t already perceivable by a trained observer. In contrast, texture
features,

second-order

descriptors,

which

quantify

the

statistical

interrelationships between voxels, can identify trends and relationships
imperceptible to the human eye. Texture features are calculated from
statistical matrices, most typically those tabulating the co-occurrence of pairs
of pixel values (gray level co-occurrence; example in Figure 1-12), or
commonality of runs of a particular pixel value (gray level run length). A near
endless amount of texture features may be generated from these matrices but
the typical starting point are the Haralick texture features, the first set of
texture features applied for image analysis and described by Haralick in
1973.109
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Figure 1-12 Diagram showing an example of texture feature value calculation
from a second-order statistical matrix. The total number of co-occurring pairs
of pixels across one direction in an image is used to create a gray level cooccurrence matrix (GLCM), whose normalized values are used for the
calculation of texture feature values. Figure from Brynolfsson et al.,
reproduced with permission.110
Machine learning algorithms applied to radiomics texture features extracted
from medical images have shown utility in a wide array of pathologies, but
have shown particular usefulness in the field of oncology. Texture features
have been used to predict tumour phenotype, histological grade, metastasis,
and patient outcome, using random forest classifiers and multivariate Cox
regression models.111-114 Texture features have also demonstrated utility in
stroke, where they have been used as input for machine learning algorithms
to predict post-stroke impairment and detect lesions using support vector
machine classifiers.115,116 Though currently limited in scope, research has
been produced showing promise for texture features in thrombus analysis;
two studies applied them to predict blood clot RBC content in vitro, with one
study using decision trees and another directly correlating features to RBC
content.117,118 Two studies have applied this technique to acute stroke
thrombi, and showed ability to predict response to rtPA and endovascular
therapies, respectively, from patient CT images in vivo using support vector
machine classifiers.119,120
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Texture features quantify image heterogeneity, and despite promising results
from algorithms applied to thrombus CT data, machine learning algorithms
have not been previously applied to stroke thrombi for the prediction of
etiology, a task where measures of intra-thrombus heterogeneity seem
particularly suited. A study utilizing a random forest classifier on texture
features derived from ex vivo MR images of acute ischemic stroke thrombi for
etiology prediction is described in the 4th chapter of this thesis. The following
section describes a subset of machine learning which has seen an explosion of
interest in recent years following advancements in computing technology,
deep learning, and the unique properties it possesses that make it a
complementary tool to machine learning for thrombus characterization. To
introduce the topic a description of the machine-learning algorithm that
forms the nexus of deep learning, the neural network, is first given.

1.7.2 Neural networks and deep learning
Originally described by Frank Rosenblott in the 1950’s, the single layer
perceptron was the earliest form of neural network; a modelling system
designed to mimic the structure of neurons within the human brain.121
Beginning with an input layer built of separate neurons for each input
feature, the perceptron’s input neurons are fully connected to a hidden layer
of neurons themselves connected to a binary output layer (Figure 1-13).
Associated with each connection is a weight parameter that quantifies the
level of influence each neuron has on the output of those it is connected to. In
iteratively updating these weight parameters based on the difference
between the desired and predicted output, a process known as network
tuning, the perceptron learns to separate between two classes of data. A
single layer perceptron is a binary linear predictor function, and is therefore
capable of differentiating only between linearly separable data classes.
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Figure 1-13: Schematic diagram of the simple perceptron. Each connection
between the input layers and the hidden layer nodes is associated with a
tuneable weight parameter (wi). Each hidden layer node performs a weighted
sum of all input features (Σi), which themselves are summed (Σj) by the
output layer. The output is determined to be true or false based on a binary
output function.
From this relatively simple starting point, more complicated neural networks
capable of performing drastically more complex operations have evolved,
becoming known as deep neural networks. While there this is no formal
definition specifying precisely when a neural network becomes complex
enough to be considered ‘deep’, certain advancements made in neural
network design since the perceptron was first described have today become
their essential properties. The inclusion of more than one hidden layer has
become the de facto defining property of deep networks, as it is necessary to
allow non-linear separation of data classes and enables more complex feature
extraction, while backpropagation allows for drastically more efficient
network tuning by allowing information from the gradient of the error
function at deeper levels to be reused by more superficial ones. Increasingly
deeper networks are capable of learning more abstract features from input
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data, to the point that handpicked, predictive input features sets are no
longer required and networks are capable of deriving their own predictive
features from comparatively raw data. Modern improvements to computing
resources and greater access to large datasets for training have, in recent
years, enabled deep neural networks to become drastically more practical and
powerful.
Within the rapid expansion of the deep learning field over the past decade,
deep learning networks designed to handle images in particular have risen in
prominence. These networks are called deep convolutional neural networks
(CNNs),

as they

use learnable convolutional

filters,

which extract

increasingly more complex patterns and features from image data. In doing
so, they learn to perform a mapping of high dimensional input data (image) to
a desired output. Over the past few years, a number of tools were developed
to improve CNN performance that have since become standard in modern
implementations. Non-linear activation functions (typically rectified linear
units (ReLu)) allow CNNs to learn features complex enough to effectively
interpret high dimensional input. Pooling and padding allow a reduction or
increase, respectively, in the dimensionality of the feature maps allowing
greater network flexibility. Batch normalization is the process of normalizing
the output of each activation layer and allows the network to learn more
quickly and avoid divergence. Dropout is the random removal of certain
output nodes, which regularizes the network, increasing generalizability and
preventing overfitting. The structure of a typical modern CNN is depicted in
Figure 1-14. Improvements in CNN design have greatly increased their
capability, and spurred translation of the technique from traditional
computer vision tasks such as character recognition,122 object detection123 and
image classification124 into the field of medical imaging.
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Figure 1-14: Architecture of a modern CNN. Three convolutional layers are
separated by ReLu’s and max pooling and/or batch normalization functions,
followed by a fully connected layer with dropout before the final output layer.
CNNs have been used for a diverse array of medical imaging applications,
ranging from detecting metastases in the brain to classifying ulcers in the
feet.125,126 In the field of stroke imaging, interest has piqued in the use of
CNNs for analysis of neurological stroke images, for the detection and
segmentation of stroke lesions and identification of penumbral tissue, for
example.127,128 The singular strength of deep neural networks comes from
their ability to derive their own abstract features, making them particularly
suited for problems where relevant imaging features are difficult to define. To
this end, CNNs have been used to abstrusely predict stroke patient prognosis,
ischemic tissue outcome, and stroke onset time.129-131
Characterization of stroke thrombi is another area where relevant imaging
features are challenging to define, and hence is suited to analysis by deep
learning networks. The interaction between RBC content and oxygenation on
quantitative MR imaging values is complex and may be difficult to capture
with traditional machine learning texture features in the context of thrombus
composition inference. Deep learning has not been previously applied towards
the analysis of human stroke thrombi, and the application of a deep CNN for
the prediction of acute stroke thrombus RBC content using ex vivo MR
images is presented in the 3rd chapter of this thesis.
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1.8 Thesis hypotheses and objectives
Despite marked improvement in stroke diagnosis and treatment in recent
years, acute ischemic stroke remains a major source of disability and
mortality across the world. Improvement in any facet of stroke care is always
desirable, but a particularly significant gap exists in the determination of
stroke etiology, a critical characteristic necessary for optimal post-stroke
management. Medical imaging is today a cornerstone of stroke care, but is
underutilized relative to its potential to compensate for weaknesses in the
current paradigm. Histological studies have identified compositional patterns
that link stroke thrombi to its underlying etiology, and while medical
imaging techniques have demonstrated a qualitative sensitivity to RBC
content, they have been thus far unable to provide accurate, quantitative
prediction of thrombus RBC content or etiology. The hypothesis of this thesis
is that quantitative MR imaging, specifically that focused on R2* and QSM
mapping, is capable of accurately characterizing ischemic stroke thrombus
RBC content and etiology through the application of machine and deep
learning image analysis algorithms. This thesis consists of 5 Chapters
designed to explore and support this hypothesis, the 1st consisting of this
introductory description of the field.
In the 2nd chapter, an in vitro study is presented which consists of a cohort of
blood clots prepared with varied RBC content and scanned serially over 6
days as their oxygenation status evolves. The objective of this work was to
demonstrate that MR R2* and QSM parameters are each sensitive to RBC
content and may be used in conjunction to allow prediction of RBC content
independent of oxygenation state. The second objective of this work was to
show that QSM and fat fraction (FF) mapping are capable of detecting
calcified and lipidic components inside thrombi.
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In the 3rd chapter, a deep learning study is presented which involves the use
of a deep CNN trained to predict RBC content using ex vivo MR images of
retrieved acute ischemic stroke thrombi. The objective of this work was to
demonstrate that CNNs are capable of learning to accurately predict RBC
content in human thrombi from R2* and QSM thrombus maps, and support
the notion that further improvements in prediction accuracy are achievable
with sufficient sample size and data augmentation.
In the 4th chapter, a machine learning study is presented which utilizes
radiomics texture features extracted from ex vivo MR images of retrieved
acute ischemic stroke thrombi to predict stroke etiology using a random
forest classifier. The objective of this work was to demonstrate that accurate
prediction of stroke etiology is possible through machine learning analysis of
texture features extracted from thrombus R2*, QSM and FF maps, and
investigate whether predictions can be improved through the incorporation of
clinical patient data.
The thesis concludes with a brief summary and suggestions for future work.

38

1.9 References
1.

Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circul
Res 2017;120:439-448.

2.

Heart_and_Stroke_Foundation. 2014 Stroke Report. 2014. Available at
http://www.strokebestpractices.ca/wpcontent/uploads/2014/06/HSF_SMReport2014E_Final.pdf (accessed
August 2018).

3.

Sposato LA, Kapral MK, Fang J, et al. Declining incidence of stroke
and dementia: coincidence or prevention opportunity? JAMA neurology
2015;72:1529-1531.

4.

Boysen G, Truelsen T. Prevention of recurrent stroke. Neurol Sci
2000;21:67-72.

5.

Mohan KM, Wolfe CD, Rudd AG, Heuschmann PU, Kolominsky-Rabas
PL, Grieve AP. Risk and cumulative risk of stroke recurrence: a
systematic review and meta-analysis. Stroke 2011;42:1489-1494.

6.

Coull AJ, Rothwell PM. Underestimation of the early risk of recurrent
stroke: evidence of the need for a standard definition. Stroke
2004;35:1925-1929.

7.

Krueger H, Koot J, Hall RE, O’callaghan C, Bayley M, Corbett D.
Prevalence of individuals experiencing the effects of stroke in Canada:
trends and projections. Stroke 2015;46:2226-2231.

8.

Boeckh-Behrens T, Kleine JF, Zimmer C, et al. Thrombus histology
suggests cardioembolic cause in cryptogenic stroke. Stroke
2016;47:1864-1871.

9.

Rudkin S, Cerejo R, Tayal A, Goldberg MF. Imaging of acute ischemic
stroke. Emerg Radiol 2018;25:659-672.

10.

Sporns PB, Hanning U, Schwindt W, et al. Ischemic Stroke: What Does
the Histological Composition Tell Us About the Origin of the
Thrombus? Stroke 2017;48:2206-2210.

11.

Ahn SH, Hong R, Choo IS, et al. Histologic features of acute thrombi
retrieved from stroke patients during mechanical reperfusion therapy.
Int J Stroke 2016;11:1036-1044.

39
12.

Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the
early management of patients with acute ischemic stroke: a guideline
for healthcare professionals from the American Heart
Association/American Stroke Association. Stroke 2018;49:e46-e99.

13.

Astrup J. Thresholds in cerebral ischemia: the ischemic penumbra.
Stroke 1981;12:723-725.

14.

Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage.
Lancet 2009;373:1632-1644.

15.

Jauch EC, Al Kasab S, Stettler B. Ischemic Stroke. New York, NY,
Medscape, 2018. Available at
https://emedicine.medscape.com/article/1916852-overview (accessed
August 2018).

16.

Williams GR, Jiang JG, Matchar DB, Samsa GP. Incidence and
occurrence of total (first-ever and recurrent) stroke. Stroke
1999;30:2523-2528.

17.

Shi Y, Wardlaw JM. Update on cerebral small vessel disease: a
dynamic whole-brain disease. Stroke Vasc Neurol 2016;1:83-92.

18.

Zakhari N, Castillo M, Torres C. Unusual cerebral emboli.
Neuroimaging Clin N Am 2016;26:147-163.

19.

Dijkhuizen RM, Rosen BR, Lo EH. Rapid breakdown of microvascular
barriers and subsequent hemorrhagic transformation after delayed
recombinant tissue plasminogen activator treatment in a rat embolic
stroke model. Stroke 2002;33:2100-2104.

20.

Murphy TH, Corbett D. Plasticity during stroke recovery: from synapse
to behaviour. Nature reviews neuroscience 2009;10:861-872.

21.

Theofanidis D. From apoplexy to brain attack, a historical perspective
on stroke to date. J Nurs Care 2015;04:e121.

22.

Disorders NIoN, Group Sr-PSS. Tissue plasminogen activator for acute
ischemic stroke. New Engl J Med 1995;333:1581-1588.

23.

Nilsen ML. A historical account of stroke and the evolution of nursing
care for stroke patients. J Neurosci Nurs 2010;42:19-27.

24.

Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early
stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS
rt-PA stroke trials. Lancet 2004;363:768-774.

40
25.

Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to
4.5 hours after acute ischemic stroke. New Engl J Med 2008;359:13171329.

26.

Von Kummer R, Bourquain H, Bastianello S, et al. Early prediction of
irreversible brain damage after ischemic stroke at CT. Radiology
2001;219:95-100.

27.

Larrue V, von Kummer R, Muller A, Bluhmki E. Risk factors for severe
hemorrhagic transformation in ischemic stroke patients treated with
recombinant tissue plasminogen activator: a secondary analysis of the
European-Australasian Acute Stroke Study (ECASS II). Stroke
2001;32:438-441.

28.

Schlaug G, Benfield A, Baird A, et al. The ischemic penumbra
operationally defined by diffusion and perfusion MRI. Neurology
1999;53:1528-1528.

29.

Sorensen AG, Buonanno FS, Gonzalez RG, et al. Hyperacute stroke:
evaluation with combined multisection diffusion-weighted and
hemodynamically weighted echo-planar MR imaging. Radiology
1996;199:391-401.

30.

Baird AE, Benfield A, Schlaug G, et al. Enlargement of human cerebral
ischemic lesion volumes measured by diffusion-weighted magnetic
resonance imaging. Ann Neurol 1997;41:581-589.

31.

Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging
profiles predict clinical response to early reperfusion: the diffusion and
perfusion imaging evaluation for understanding stroke evolution
(DEFUSE) study. Ann Neurol 2006;60:508-517.

32.

Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond
3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation
Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol
2008;7:299-309.

33.

Boulanger J, Lindsay M, Gubitz G, et al. Canadian stroke best practice
recommendations for acute stroke management: prehospital,
emergency department, and acute inpatient stroke care, update 2018.
Int J Stroke 2018;13:949-984.

34.

Lansberg MG, Straka M, Kemp S, et al. MRI profile and response to
endovascular reperfusion after stroke (DEFUSE 2): a prospective
cohort study. Lancet Neurol 2012;11:860-867.

41
35.

Campbell BCV, Christensen S, Levi CR, et al. Comparison of computed
tomography perfusion and magnetic resonance imaging perfusiondiffusion mismatch in ischemic stroke. Stroke 2012;43:2648-2653.

36.

Campbell BC, Mitchell PJ, Yan B, et al. A multicenter, randomized,
controlled study to investigate EXtending the time for Thrombolysis in
Emergency Neurological Deficits with Intra-Arterial therapy
(EXTEND-IA). Int J Stroke 2014;9:126-132.

37.

Casaubon LK, Boulanger J-M, Blacquiere D, et al. Canadian stroke
best practice recommendations: hyperacute stroke care guidelines,
update 2015. Int J Stroke 2015;10:924-940.

38.

Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24
hours after stroke with a mismatch between deficit and infarct. New
Engl J Med 2018;378:11-21.

39.

Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to
16 hours with selection by perfusion imaging. New Engl J Med
2018;378:708-718.

40.

Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C.
Long-term risk of recurrent stroke after a first-ever stroke. The
Oxfordshire Community Stroke Project. Stroke 1994;25:333-337.

41.

Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype
of acute ischemic stroke. Definitions for use in a multicenter clinical
trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke
1993;24:35-41.

42.

Radu RA, Terecoasă EO, Băjenaru OA, Tiu C. Etiologic classification of
ischemic stroke: where do we stand? Clin Neurol Neurosurg
2017;159:93-106.

43.

Nam HS, Kim HC, Kim YD, et al. Long-term mortality in patients with
stroke of undetermined etiology. Stroke 2012;43:2948-2956.

44.

Libby P. Current concepts of the pathogenesis of the acute coronary
syndromes. Circulation 2001;104:365-372.

45.

Ogata J, Yutani C, Otsubo R, et al. Heart and vessel pathology
underlying brain infarction in 142 stroke patients. Ann Neurol
2008;63:770-781.

42
46.

Bos D, van der Rijk MJ, Geeraedts TE, et al. Intracranial carotid
artery atherosclerosis: prevalence and risk factors in the general
population. Stroke 2012;43:1878-1884.

47.

Sobiczewski W, Wirtwein M, Trybala E, Gruchala M. Severity of
coronary atherosclerosis and stroke incidence in 7-year follow-up. J
Neurol 2013;260:1855-1858.

48.

Molteni M, Polo Friz H, Primitz L, Marano G, Boracchi P, Cimminiello
C. The definition of valvular and non-valvular atrial fibrillation:
results of a physicians' survey. Europace 2014;16:1720-1725.

49.

Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in
cardiac surgical patients with atrial fibrillation. Ann Thorac Surg
1996;61:755-759.

50.

Corrado G, Tadeo G, Beretta S, et al. Atrial thrombi resolution after
prolonged anticoagulation in patients with atrial fibrillation: a
transesophageal echocardiographic study. Chest 1999;115:140-143.

51.

Hannon N, Sheehan O, Kelly L, et al. Stroke associated with atrial
fibrillation – incidence and early outcomes in the North Dublin
population stroke study. Cerebrovasc Dis 2009;29:43-49.

52.

Lammie GA. Pathology of small vessel stroke. Br Med Bull
2000;56:296-306.

53.

Jackson C, Sudlow C. Are lacunar strokes really different? A
systematic review of differences in risk factor profiles between lacunar
and nonlacunar infarcts. Stroke 2005;36:891-901.

54.

De Jong G, Van Raak L, Kessels F, Lodder J. Stroke subtype and
mortality: a follow-up study in 998 patients with a first cerebral
infarct. J Clin Epidemiol 2003;56:262-268.

55.

Wein T, Lindsay MP, Côté R, et al. Canadian stroke best practice
recommendations: secondary prevention of stroke, practice guidelines,
update 2017. Int J Stroke 2018;13:420-443.

56.

Evans A, Perez I, Yu G, Kalra L. Should stroke subtype influence
anticoagulation decisions to prevent recurrence in stroke patients with
atrial fibrillation? Stroke 2001;32:2828-2832.

57.

Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic
therapy to prevent stroke in patients who have nonvalvular atrial
fibrillation. Ann Intern Med 2007;146:857-867.

43
58.

Ziegler PD, Koehler JL, Mehra R. Comparison of continuous versus
intermittent monitoring of atrial arrhythmias. Heart Rhythm
2006;3:1445-1452.

59.

Landau WM, Nassief A. Editorial comment—time to burn the TOAST.
Stroke 2005;36:902-904.

60.

Chang Y-J, Ryu S-J, Lin S-K. Carotid artery stenosis in ischemic
stroke patients with nonvalvular atrial fibrillation. Cerebrovasc Dis
2002;13:16-20.

61.

Furie B, Furie BC. Mechanisms of thrombus formation. New Engl J
Med 2008;359:938-949.

62.

Swystun LL, Liaw PC. The role of leukocytes in thrombosis. Blood
2016;128:753-762.

63.

Litvinov RI, Weisel JW. Role of red blood cells in haemostasis and
thrombosis. ISBT Science Series 2017;12:176-183.

64.

Staessens S, Denorme F, François O, et al. Structural analysis of
ischemic stroke thrombi: histological indications for therapy resistance.
Haematologica 2020;105:498-507.

65.

Bajd F, Vidmar J, Fabjan A, et al. Impact of altered venous
hemodynamic conditions on the formation of platelet layers in
thromboemboli. Thromb Res 2012;129:158-163.

66.

Marder VJ, Chute DJ, Starkman S, et al. Analysis of thrombi retrieved
from cerebral arteries of patients with acute ischemic stroke. Stroke
2006;37:2086-2093.

67.

Liebeskind DS, Sanossian N, Yong WH, et al. CT and MRI early vessel
signs reflect clot composition in acute stroke. Stroke 2011;42:12371243.

68.

Sato Y, Ishibashi-Ueda H, Iwakiri T, et al. Thrombus components in
cardioembolic and atherothrombotic strokes. Thromb Res
2012;130:278-280.

69.

Boeckh-Behrens T, Schubert M, Förschler A, et al. The impact of
histological clot composition in embolic stroke. Clin Neuroradiol
2014;26:189-197.

70.

Niesten JM, van der Schaaf IC, van Dam L, et al. Histopathologic
composition of cerebral thrombi of acute stroke patients is correlated

44
with stroke subtype and thrombus attenuation. PLoS One
2014;9:e88882.
71.

Sallustio F, Arnò N, Legge SD, et al. Histological features of
intracranial thrombo-emboli predict response to endovascular therapy
for acute ischemic stroke. J Neurol Disord Stroke 2015;3:1105.

72.

Kim S, Yoon W, Kim T, Kim H, Heo T, Park M. Histologic analysis of
retrieved clots in acute ischemic stroke: correlation with stroke etiology
and gradient-echo MRI. AJNR Am J Neuroradiol 2015;36:1756-1762.

73.

Simons N, Mitchell P, Dowling R, Gonzales M, Yan B. Thrombus
composition in acute ischemic stroke: A histopathological study of
thrombus extracted by endovascular retrieval. J Neuroradiol
2015;42:86-92.

74.

Maekawa K, Shibata M, Nakajima H, et al. Erythrocyte-rich thrombus
is associated with reduced number of maneuvers and procedure time in
patients with acute ischemic stroke undergoing mechanical
thrombectomy. Cerebrovasc Dis Extra 2018;8:39-49.

75.

Fitzgerald S, Dai D, Wang S, et al. Platelet-rich emboli in cerebral
large vessel occlusion are associated with a large artery atherosclerosis
source. Stroke 2019;50:1907-1910.

76.

Chueh J, Wakhloo A, Hendricks G, Silva C, Weaver J, Gounis M.
Mechanical characterization of thromboemboli in acute ischemic stroke
and laboratory embolus analogs. AJNR Am J Neuroradiol
2011;32:1237-1244.

77.

Almekhlafi MA, Hu WY, Hill MD, Auer RN. Calcification and
endothelialization of thrombi in acute stroke. Ann Neurol 2008;64:344347.

78.

Dobrocky T, Piechowiak E, Cianfoni A, et al. Thrombectomy of calcified
emboli in stroke. Does histology of thrombi influence the effectiveness
of thrombectomy? J Neurointerv Surg 2017;10:345-350.

79.

McMeekin P, White P, James MA, Price CI, Flynn D, Ford GA.
Estimating the number of UK stroke patients eligible for endovascular
thrombectomy. Eur Stroke J 2017;2:319-326.

80.

Duloquin G, Graber M, Garnier L, et al. Incidence of acute ischemic
stroke with visible arterial occlusion: a population-based study (Dijon
Stroke Registry). Stroke 2020;51:2122-2130.

45
81.

Baek J-H, Kim BM, Heo JH, et al. Number of stent retriever passes
associated with futile recanalization in acute stroke. Stroke
2018;49:2088-2095.

82.

Gomori JM, Grossman RI. Mechanisms responsible for the MR
appearance and evolution of intracranial hemorrhage. Radiographics
1988;8:427-440.

83.

Kirchhof K, Welzel T, Mecke C, Zoubaa S, Sartor K. Differentiation of
white, mixed, and red thrombi: value of CT in estimation of the
prognosis of thrombolysis phantom study. Radiology 2003;228:126-130.

84.

Rovira A, Orellana P, Alvarez-Sabín J, et al. Hyperacute ischemic
stroke: middle cerebral artery susceptibility sign at echo-planar
gradient-echo MR imaging. Radiology 2004;232:466-473.

85.

Brinjikji W, Michalak G, Kadirvel R, et al. Utility of single-energy and
dual-energy computed tomography in clot characterization: an in-vitro
study. Interv Neuroradiol 2017;23:279-284.

86.

Flacke S, Urbach H, Keller E, et al. Middle cerebral artery (MCA)
susceptibility sign at susceptibility-based perfusion MR imaging:
clinical importance and comparison with hyperdense MCA sign at CT
1. Radiology 2000;215:476-482.

87.

Mair G, Boyd EV, Chappell FM, et al. Sensitivity and specificity of the
hyperdense artery sign for arterial obstruction in acute ischemic
stroke. Stroke 2015;46:102-107.

88.

Shin JW, Jeong HS, Kwon H-J, Song KS, Kim J. High red blood cell
composition in clots is associated with successful recanalization during
intra-arterial thrombectomy. PLoS One 2018;13:e0197492.

89.

Choi MH, Park GH, Lee JS, et al. Erythrocyte fraction within retrieved
thrombi contributes to thrombolytic response in acute ischemic stroke.
Stroke 2018;49:652-659.

90.

Puig J, Pedraza S, Demchuk A, et al. Quantification of thrombus
hounsfield units on noncontrast CT predicts stroke subtype and early
recanalization after intravenous recombinant tissue plasminogen
activator. AJNR Am J Neuroradiol 2012;33:90-96.

91.

Yamamoto N, Satomi J, Tada Y, et al. Two-layered susceptibility vessel
sign on 3-Tesla T2*-weighted imaging is a predictive biomarker of
stroke subtype. Stroke 2015;46:269-271.

46
92.

Horie N, Tateishi Y, Morikawa M, et al. Acute stroke with major
intracranial vessel occlusion: characteristics of cardioembolism and
atherosclerosis-related in situ stenosis/occlusion. J Clin Neurosci
2016;32:24-29.

93.

Brinjikji W, Duffy S, Burrows A, et al. Correlation of imaging and
histopathology of thrombi in acute ischemic stroke with etiology and
outcome: a systematic review. J Neurointerv Surg 2017;9:529-534.

94.

Bourcier R, Détraz L, Serfaty JM, et al. MRI interscanner agreement
of the association between the susceptibility vessel sign and histologic
composition of thrombi. J Neuroimaging 2017;27:577-582.

95.

Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder
SB. Multiecho water‐fat separation and simultaneous R2* estimation
with multifrequency fat spectrum modeling. Magn Reson Med
2008;60:1122-1134.

96.

Hernando D, Kellman P, Haldar J, Liang ZP. Robust water/fat
separation in the presence of large field inhomogeneities using a graph
cut algorithm. Magn Reson Med 2010;63:79-90.

97.

Liu J, Drangova M. Method for B0 off-resonance mapping by noniterative correction of phase-errors (B0-NICE). Magn Reson Med
2015;74:1177-1188.

98.

Jain V, Abdulmalik O, Propert KJ, Wehrli FW. Investigating the
magnetic susceptibility properties of fresh human blood for
noninvasive oxygen saturation quantification. Magn Reson Med
2012;68:863-867.

99.

de Rochefort L, Liu T, Kressler B, et al. Quantitative susceptibility
map reconstruction from MR phase data using bayesian regularization:
validation and application to brain imaging. Magn Reson Med
2010;63:194-206.

100.

Sun H, Kate M, Gioia LC, Emery DJ, Butcher K, Wilman AH.
Quantitative susceptibility mapping using a superposed dipole
inversion method: application to intracranial hemorrhage. Magn Reson
Med 2016;76:781-791.

101.

Liu J, Liu T, de Rochefort L, et al. Morphology enabled dipole inversion
for quantitative susceptibility mapping using structural consistency
between the magnitude image and the susceptibility map. NeuroImage
2012;59:2560-2568.

47
102.

Bourcier R, Pautre R, Mirza M, et al. MRI quantitative T2* mapping to
predict dominant composition of in vitro thrombus. AJNR Am J
Neuroradiol 2019;40:59-64.

103.

Chang S, Zhang J, Liu T, et al. Quantitative susceptibility mapping of
intracerebral hemorrhages at various stages: mapping of intracerebral
hemorrhages. J Magn Reson Imaging 2016;44:420-425.

104.

Shinohara Y, Kato A, Yamashita E, Ogawa T. R2* map by IDEAL IQ
for acute cerebral infarction: compared with susceptibility vessel sign
on T2*-weighted imaging. Yonago Acta Med 2016;59:204.

105.

Di Meglio L, Desilles J-P, Ollivier V, et al. Acute ischemic stroke
thrombi have an outer shell that impairs fibrinolysis. Neurology
2019;93:e1686-e1698.

106.

Fernández-Delgado M, Cernadas E, Barro S, Amorim D. Do we need
hundreds of classifiers to solve real world classification problems? J
Mach Learn Res 2014;15:3133-3181.

107.

Breiman L. Random forests. Mach Learn 2001;45:5-32.

108.

Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than
pictures, they are data. Radiology 2016;278:563-577.

109.

Haralick RM, Shanmugam K, Dinstein IH. Textural features for image
classification. IEEE Trans Syst Man Cybern 1973:610-621.

110.

Brynolfsson P, Nilsson D, Torheim T, et al. Haralick texture features
from apparent diffusion coefficient (ADC) MRI images depend on
imaging and pre-processing parameters. Sci Rep 2017;7:1-11.

111.

Aerts HJWL, Velazquez ER, Leijenaar RTH, et al. Decoding tumour
phenotype by noninvasive imaging using a quantitative radiomics
approach. Nat Commun 2014;5:1-9.

112.

Zhou H, Vallières M, Bai HX, et al. MRI features predict survival and
molecular markers in diffuse lower-grade gliomas. Neuro Oncol
2017;19:862-870.

113.

Vallières M, Freeman CR, Skamene SR, El Naqa I. A radiomics model
from joint FDG-PET and MRI texture features for the prediction of
lung metastases in soft-tissue sarcomas of the extremities. Phys Med
Biol 2015;60:5471-5496.

48
114.

Kim HS, Kim YJ, Kim KG, Park JS. Preoperative CT texture features
predict prognosis after curative resection in pancreatic cancer. Sci Rep
2019;9:1-9.

115.

Rajini NH, Bhavani R. Computer aided detection of ischemic stroke
using segmentation and texture features. Measurement 2013;46:18651874.

116.

Betrouni N, Yasmina M, Bombois S, et al. Texture features of magnetic
resonance images: an early marker of post-stroke cognitive
impairment. Transl Stroke Res 2020;11:643-652.

117.

Gonzalez AV, Buerke B, Görlich D, et al. Clot analog attenuation in
non-contrast CT predicts histology: an experimental study using
machine learning. Transl Stroke Res 2020;11:940-949.

118.

Bretzner M, Lopes R, McCarthy R, et al. Texture parameters of R2*
maps are correlated with iron concentration and red blood cells count
in clot analogs: a 7-T micro-MRI study. J Neuroradiol 2019;47:306-311.

119.

Qiu W, Kuang H, Nair J, et al. Radiomics-based intracranial thrombus
features on CT and CTA predict recanalization with intravenous
alteplase in patients with acute ischemic stroke. AJNR Am J
Neuroradiol 2019;40:39-44.

120.

Hofmeister J, Bernava G, Rosi A, et al. Clot-based radiomics predict a
mechanical thrombectomy strategy for successful recanalization in
acute ischemic stroke. Stroke 2020;51:2488-2494.

121.

Rosenblatt F. The perceptron: a probabilistic model for information
storage and organization in the brain. Psychol Rev 1958;65:386.

122.

LeCun Y, Bottou L, Bengio Y, Haffner P. Gradient-based learning
applied to document recognition. Proc IEEE. Volume 86; 1998. p. 22782324.

123.

Zhang C, Platt JC, Viola PA. Multiple instance boosting for object
detection. Adv Neural Inf Process Syst; 2006. p. 1417-1424.

124.

Krizhevsky A, Sutskever I, Hinton GE. Imagenet classification with
deep convolutional neural networks. Adv Neural Inf Process Syst;
2012. p. 1097-1105.

125.

Charron O, Lallement A, Jarnet D, Noblet V, Clavier J-B, Meyer P.
Automatic detection and segmentation of brain metastases on

49
multimodal MR images with a deep convolutional neural network.
Comput Biol Med 2018;95:43-54.
126.

Alzubaidi L, Fadhel MA, Oleiwi SR, Al-Shamma O, Zhang J.
DFU_QUTNet: diabetic foot ulcer classification using novel deep
convolutional neural network. Multimed Tools Appl 2020;79:1565515677.

127.

Liu L, Chen S, Zhang F, Wu F-X, Pan Y, Wang J. Deep convolutional
neural network for automatically segmenting acute ischemic stroke
lesion in multi-modality MRI. Neural Comput Appl 2019:1-14.

128.

Wang K, Shou Q, Ma SJ, et al. Deep learning detection of penumbral
tissue on arterial spin labeling in stroke. Stroke 2020;51:489-497.

129.

Choi Y, Kwon Y, Lee H, Kim BJ, Paik MC, Won J-H. Ensemble of deep
convolutional neural networks for prognosis of ischemic stroke.
International Workshop on Brainlesion: Glioma, Multiple Sclerosis,
Stroke and Traumatic Brain Injuries: Springer; 2016. p. 231-243.

130.

Nielsen A, Hansen MB, Tietze A, Mouridsen K. Prediction of tissue
outcome and assessment of treatment effect in acute ischemic stroke
using deep learning. Stroke 2018;49:1394-1401.

131.

Ho KC, Speier W, El-Saden S, Arnold CW. Classifying acute ischemic
stroke onset time using deep imaging features. AMIA Annual
Symposium Proceedings: American Medical Informatics Association;
2017. p. 892.

50

CHAPTER 2

Simultaneous R2* and QSM measurement
enables differentiation of thrombus
hematocrit and age: an in vitro study at 3T

2.1 Introduction
Recanalization has been established as the definitive treatment for acute
ischemic

stroke,1

however

the

efficacy

of

common

fibrinolytic

and

endovascular thrombectomy therapies is influenced by underlying thrombus
composition.2,3 Stroke thrombi consist principally of red blood cells, fibrin and
platelets, though relative proportions vary widely.4 In certain cases, calcium
or cholesterol crystals may be incorporated within, or even form the majority
of, an embolic thrombus;5,6 calcium interferes with fibrinolytic therapy,7 and
both calcium and cholesterol affect thrombus mechanical properties.6
Thrombus age may also affect lysis rate and indicate underlying etiology. 8,9
Magnetic resonance imaging (MRI) has demonstrated utility in the detection
and staging of ischemic stroke,10 but an evolving understanding of the
implications of thrombus composition motivates the development of imagingbased thrombus characterization methods, which offer to non-invasively aid
decision-making in acute stroke treatment and support determination of the
embolic source.
Imaging-based characterization of thrombi in vivo has largely been achieved
through qualitative metrics such as the appearance of a susceptibility-based
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blooming artifact on MRI or a hyperdense sign on computed tomography
(CT).11,12 Though shown to be correlated to red blood cell proportion, such
signs have proven inconsistent when applied towards association with
underlying thrombus etiology,13 may be mimicked by the appearance of
calcium14 and are insensitive to lipidic components. Quantitative MRI
characterization methods utilizing diffusion or relaxation parameters have
been successfully applied in preclinical models, but require lengthy scan
times that are prohibitive in the clinic.15,16 Relaxation and quantitative
susceptibility

mapping

(QSM)

parameters

have

been

measured

for

experimental blood clots in vitro,17,18 but did not include calcified or lipidic
components and either compared multiple clots of different composition at
one time or measured changes in a single clot over time. Because clinical
thrombi vary in both composition and age, and each affects MR
characteristics, both aspects must be considered if knowledge gained from in

vitro characterization is to be extended to clinical application.
Three-dimensional (3D) multi-echo gradient echo (GRE) acquisitions offer an
opportunity to derive multiple quantitative imaging parameters in the form
of quantitative maps from a single scan. The acquisition of multiple early
echoes at various fat-water phase shifts allows for simultaneous protondensity fat fraction (FF), R2* and B0 mapping through Dixon MRI postprocessing,19 while the acquisition of multiple echoes at late echo times is
required for sufficient susceptibility weighting to perform QSM mapping. 20
Recently, a novel multi-echo GRE acquisition and analysis approach has
combined an early, short-echo-spacing echo train (to enable Dixon MRI) with
a large-echo-spacing echo train (to capture susceptibility variation and
additional R2* information).21 Together, the post-processing algorithms and
dual-echo-train GRE acquisition have the potential to provide multiple
quantitative

imaging

parameters

(FF,

R2*,

B0,

QSM)

suitable

for

characterization of thrombus from a single 3D scan. In this study, we
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examine the ability of R2*, QSM and FF values to characterize blood clot of
varying hematocrit formed in vitro, some containing calcified and lipidic
components, across an age range relevant to thrombi causing stroke.
Specifically, we quantified R2* and QSM values of in vitro clot throughout
ageing up to 6 days, examined the ability of the derived values to
discriminate between various clot hematocrit and age, and finally assessed
the ability to predict clot hematocrit and age from measured R2* and QSM
values. Additionally, we compared the ability of standard clinical MRI
thrombus assessment techniques (i.e. late-echo GRE magnitude) to R2*, QSM
and FF maps for detecting calcified and lipidic components within clots of
various hematocrit and age.

2.2 Materials and methods
2.2.1 Phantom preparation
Thrombus phantoms were constructed using arterial porcine blood collected
from a local abattoir and anti-coagulated with 0.109 M buffered sodium
citrate (Medicago AB; Danmark, Sweden) in a 1:9 ratio. The anti-coagulated
blood was centrifuged at 300 g for 10 minutes, the supernatant plasma was
extracted and spun again at 300 g for 10 minutes to derive platelet-rich and
platelet-poor plasma (PRP and PPP, respectively). Separate whole blood
samples were spun at 775 g for 15 minutes to isolate red blood cells (RBCs).
Blood samples of controlled hematocrit (10, 20, 30, 50, 40 and 60%) were
prepared by mixing RBCs and PRP; two 5 mL samples of each hematocrit
were placed inside 1 cm diameter polystyrene vials (chosen to have a minimal
effect on QSM, <0.005 ppm shifts observed in water samples). Antibiotic
(100X

stock,

Gibco

Antibiotic-Antimycotic;

Thermo

Fisher

Scientific;

Waltham, MA) and 500 mmol/L calcium chloride (Caledon Laboratory
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Chemicals; Georgetown, Canada) solutions were added to each sample
achieving final dilutions of 1/100 and 1/45, respectively. Finally, clotting was
induced by thromboplastin (Thermo Fisher Scientific; Waltham, MA) at a
1/3000 final dilution. To mitigate clot retraction, clots were left undisturbed
in the vials throughout the experiment. The time at which thromboplastin
was added was considered to be the time of clot formation (t = 0). All clot vials
were placed vertically into a preformed agar-filled container (3.5% agar, 8%
glycerol, 2% formalin solution (neutral buffered, 10%)); samples were
arranged concentrically within the phantom, and a vial containing peanut oil
was placed in its centre to act as a control sample during FF mapping. The
phantom was kept in a 37 °C water bath between scans to replicate biological
conditions for clot ageing and will be referred to as the ‘blood-only’ thrombus
phantom.
To emulate clinical thrombi containing lipid, a separate thrombus phantom
was prepared using identical methodology (hematocrit of 0, 20, 40 and 60%)
but a piece of lard (~2.5 mm cube; local abattoir) was added to each of the
blood samples (2 mL) immediately following the injection of thromboplastin.
In this case the samples were left to coagulate at room temperature for one
hour following thromboplastin injection, at which point 3 mL of PPP was
added to fill the remaining air space above the formed multi-component clots
within each vial. A sample containing a whole-blood clot (approximately 30%
hematocrit) with an added piece of agar containing 5M calcium carbonate to
simulate the presence of calcified tissue14 was also prepared.

2.2.2 Image acquisition
All imaging experiments were performed on a 3.0 T whole-body MRI scanner
(GE 750, GE Medical Systems, Milwaukee, WI) using a 32-channel receive
head coil. B0 and B1 shimming were performed prior to each imaging session.
Scans were acquired using a 3D multi-echo bipolar GRE sequence designed
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for clinical imaging in vivo; the sequence includes two 5-echo trains: the first
train was optimized for chemical shift imaging (first echo time (TE) = 3.20
ms, echo spacing = 1.46 ms); the second train was optimized to highlight
susceptibility-related contrast at the level commonly observed within human
brain in vivo (first TE = 16.75 ms, echo spacing = 7.15 ms). The remaining
scan parameters were repetition time = 47.6 ms, bandwidth = 142.86 kHz,
flip angle = 10°; field of view = 18 cm; matrix size = 192 × 192 × 42, for a final
voxel dimension of 0.94 × 0.94 × 1.0 mm3. Bipolar readout enabled the in-andout of phase fat/water acquisition during the first echo train. No acceleration
or averaging was used; the total acquisition time was 6 minutes 28 seconds.
All phantoms were scanned in the coronal plane, with the vials aligned
perpendicular to B0; clots were thus kept vertical throughout the experiment,
limiting retraction and the introduction of air bubbles. The blood-only
thrombus phantom was initially scanned every 15 minutes without
repositioning from 30 minutes to 6 hours to investigate the MRI properties of
acute thrombi; scans were then acquired at 22 and 26 hours and 2, 3 and 6
days post clotting to represent chronic thrombus. The thrombus phantom
containing lard was scanned at 3, 7 and 18 hours, then daily for one week;
the calcium-containing clot was scanned at 2 hours and at 2 days post
clotting.

2.2.3 Image reconstruction and multi-parameter mapping
Image reconstruction and multi-parameter map generation were performed
in Matlab (Matlab 8 R2015a; Mathworks, Natick, MA). Raw image data were
reconstructed off-line using the Orchestra Software Development Kit (GE
Healthcare; Milwaukee, WI). Complex channel combination was performed
using singular value decomposition and phase errors resulting from the
bipolar acquisition were removed.21 Fat fraction, B0 and R2* maps were
generated using the B0-NICE algorithm.19 Briefly, the B0-NICE algorithm
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utilizes magnitude data processed independently to generate FF and R 2*
estimate maps, unwrapped phase data to generate initial phase-based B0 and
FF maps, and then uses the derived magnitude-based FF map to correct for
phase errors existing in phase-based B0 and FF maps to generate the final B0
and FF maps. The algorithm was used with the first 5 acquired echoes to
produce FF and B0 maps, and all 10 echoes for the generation of R2* maps.
QSM maps were generated using the MEDI QSM algorithm20 implemented
on all 10 echoes of the channel-combined complex data, with the λ
regularization parameter set to 1000 and maximum iterations set to 10. The
Laplacian boundary value method was used for background field removal,
with tolerance, depth and peel set to 0.005, -1 and 0, respectively.
The performance of the reconstruction and mapping algorithms described
above was evaluated using a calibration phantom with known FF, QSM and
R2*. Details pertaining to calibration phantom fabrication, analysis, and
associated results are presented in Supplementary Material.

2.2.4 Image analysis
Segmentation of the blood-only clots and blood-only regions of clots
containing lard or calcium was completed by using cylindrical regions of
interest (ROIs) (~7-mm diameter and ~10-mm tall) to derive sample mean
and standard deviation values for all measured parameters; care was taken
to position ROIs to contain only clotted blood and exclude added lard or
calcium when present, as well as slices showing clot retraction. The calcium
and lard were segmented via thresholding applied within the clot on QSM
and FF maps, respectively; the threshold for FF was 0.5 and that for QSM
maps was -0.1 ppm. Image analysis was performed using Matlab.
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2.2.5 Data analysis
The ability of simultaneously measured R2* and QSM values to estimate the
age and hematocrit of the clots was evaluated. Clots aged 6 hours were
considered acute and those aged >6 hours were considered chronic. Receiver
operator characteristic (ROC) analysis was performed to derive the R2* and
QSM thresholds that optimally differentiate acute from chronic clots. To
estimate hematocrit in acute clots, linear regression was applied to determine
the relationship between hematocrit and QSM values, while for chronic clots
hematocrit was fitted as a decaying exponential function of the R2*/QSM
ratio; all fitting was performed using data from six of the twelve clots (one
from each pair, of each hematocrit). The remaining six clots were used to
evaluate the performance of the derived relationships to predict hematocrit in
both acute and chronic states. All data analysis was performed using
GraphPad Prism (v7.0; GraphPad Software, La Jolla, CA).

2.3 Results
2.3.1 Acute clot (6 hours)
Figure 2-1 illustrates representative R2* and QSM maps and values derived
from the blood-only thrombus phantom in the acute phase (i.e. first 6 hours
post clotting). R2* increased with hematocrit but was nearly identical for the
40-60% hematocrit clots (Figure 2-1C). A small, consistent increase in R2* was
observed over time, with the slope increasing markedly between the 10% and
20% clots (0.04 s-1hr-1 and 0.31 s-1hr-1, respectively); the slope plateaued at
approximately 0.5 s-1hr-1 for the 40-60% hematocrit clots. Over the six-hour
period clot QSM values remained constant (Figure 2-1D) and were linearly
proportional to hematocrit. The consistency of R2* and QS values between
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clots of the same composition at the six-hour time point is shown in Figures
2-1E and F; similar consistency was observed at all acute time points, as
expected.

Figure 2-1: Acute blood clot relaxation and magnetic susceptibility
quantification; shown are the central coronal slices of the (A) R2* [0 s-1, 80 s-1]
and (B) QSM [-0.5 ppm, 0.5 ppm] maps for the blood-only thrombus phantom
at 6 hours post clotting. The mean (C) R2* and (D) QSM values of an
individual clot from each pair (10 to 60% hematocrit) are shown over the first
6 hours post clotting; error bars were omitted for clarity. The mean and
standard deviation of each clot pair with the same nominal hematocrit at the
six hour time point are shown for (E) R2* and (F) QSM, demonstrating
reproducibility.

2.3.2 Chronic clot (>6 hours)
The effects of chronic ageing (up to six days) on mean R2* and QSM values are
shown in Figure 2-2. R2* increased rapidly over the first 40 hours (up to 4.0 s-
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1hr-1

for 40-60% hematocrit), before reaching a plateau after the 44 hour scan

(Figure 2-2A). High hematocrit clots (over 40%) were indistinguishable from
each other on the basis of R2*. Measured QSM increased in proportion to clot
hematocrit over the first 44 hours and remained constant for the remainder
of the experiment (Figure 2-2B). Unlike R2*, QSM was linearly related to clot
hematocrit at all time points. Because both R2* and QSM changed over time,
neither could be used alone to infer hematocrit in a thrombus of unknown
age. A plot of R2* against QSM (Figure 2-2C), demonstrates a linear
relationship with a unique slope at all hematocrits – decreasing from 325 to
173 s-1ppm-1 as hematocrit increased from 10 to 60%, suggesting that
hematocrit may be estimated from the R2*/QSM ratio.

2.3.3 Acute and chronic clot differentiation
The receiver-operating-characteristic analysis used to derive R2* and QSM
thresholds that differentiate between acute and chronic clots yielded a QSM
threshold of 0.165 ppm with a corresponding sensitivity and specificity of 85
and 92%, respectively; the area under the curve (AUC) was 0.932 (95% CI
0.892 to 0.972; p<0.0001). All acute clots had mean R2* below 22 s-1, while
chronic clots had an R2* greater than 24 s-1 (i.e. 100% sensitivity and
specificity; AUC =1).

2.3.4 Clot hematocrit prediction
The ability to use measured R2* and QSM to predict clot hematocrit at any
age is demonstrated in Figure 2-3. For acute clots, Figure 2-3A shows that
hematocrit can be estimated from QSM (HCT = 260*QSM + 9%; where HCT
is the hematocrit percentage; R2 = 0.97). For chronic clots, Figure 2-3B shows
that hematocrit can be estimated from the R2*/QSM ratio (HCT = 125.3*exp(0.007*R2*/QSM) + 4.2%; R2 = 0.77). Evaluation of the ability to predict clot
hematocrit, calculated for the remaining six clots in the phantom, yielded a
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mean absolute error of 4.9 ± 3.1% for the acute clots and 8.3 ± 5.4% for the
chronic clots.

Figure 2-2: Blood clot R2* and QSM of chronic clots throughout ageing; (A) R2*
and (B) QSM values of blood-only clots from 6 up to 144 hours post clotting
(the 6-hr time point is included in order to relate these results to those of the
acute clots of Figure 2-1). Plotted are mean values of individual clots;
standard deviation error bars of only the 60% hematocrit clots are shown for
clarity, error bars for QSM were smaller than the symbols. (C) Scatter plot
and linear regression of R2* versus QSM values at all time points for clots of
each hematocrit.
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Figure 2-3: Relationship between hematocrit and measured quantitative
imaging values in acute (≤6 hours) and chronic (>6 hours) clot. (A) Acute clot
hematocrit can be estimated linearly from measured QSM values, while (B)
chronic clot hematocrit can be estimated from an exponential relation of the
ratio of R2* / QSM. Shown are data points from the same 6 clots (one from
each pair of 10 to 60% hematocrit) plotted in Figures 2-1 and 2-2.

61

2.3.5 Identification of lipid and calcifications within clot
Representative images from the lard clot phantom are displayed in Figure 24. Results from two time points are shown – the 7-hour time point
representing acute (Figures 2-4A, C) and the 4-day time point representing
chronic clot (Figures 2-4B, D). The magnitude images (Figures 2-4A, B) are
representative

of

GRE

acquisitions

commonly

used

for

thrombus

characterization. As expected, the TE=4.2 ms magnitude images show no
ability to differentiate hematocrit, while the TE=31 ms magnitude images
demonstrate a decrease in signal intensity with increasing hematocrit in the
chronic clot (Figure 2-4B). However, this signal loss eliminates contrast
between the clot and lard. The quantitative R2*, QSM and FF maps (Figures
2-4C, D) demonstrate that differentiation between clot and lipid components
is possible independent of the clot age or hematocrit; the lard is clearly
distinguishable based on its high FF (mean: 0.78 ± 0.02). Similar results are
observed in the clot containing agar with 5M calcium carbonate (Figure 2-5),
where the calcium is readily distinguishable from clot due to its diamagnetic
QSM value (mean: -0.34 ± 0.08 ppm) at both two hours and two days post
clotting (Figures 2-5A, B).
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Figure 2-4: Regions (1.2 × 1.4 mm) from representative sagittal slices through
select clots (0, 20, 40% hematocrit) in the lard clot phantom demonstrating
discriminability of the added component; shown are early and late echo
magnitude images of clots within the phantom at (A) 7 hours and (B) 4 days
post clotting. These images represent the current standard technique for
thrombus characterization; lard is either visible within clot as a nondescript
area of low signal (red arrows) or is undetectable because of signal void
produced by chronic clot (B; 20 and 40% clots at 31 ms). R2*, QSM and fat
fraction (FF) maps of the phantom are shown at (C) 7 hours and (D) 4 days
post clotting. Lipid is readily distinguishable from clot by its elevated FF
value in clots of all hematocrits whether acute or chronic. Noticeable
differences in R2* and QSM values between clots of different hematocrit can
also be observed in the chronic clots in (D).

Figure 2-5: Regions (1.2 × 1.4 mm) from representative sagittal slices through
a single whole-blood clot with an added piece of agar containing 5M calcium
carbonate (red arrows); shown are early and late echo magnitude images at
(A) 2 hours and (B) 2 days post clotting. Similar to the appearance of the lard
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added to clot, calcium carbonate shows low signal on early and late
magnitude images, but differs with high R2*, low QSM and low FF values.
The calcium carbonate is definitively identified within both acute and chronic
clot by its negative QSM values (black in the QSM maps of (B)).

2.4 Discussion
This study demonstrates the use of R2*, QSM and FF maps to characterize
and differentiate blood clot based on hematocrit and age, as well as to
identify calcified and lipidic components when present. Such quantitative
information

provides

a

non-invasive

tool

to

characterize

thrombus

composition, and to potentially inform decisions in the management and
treatment of acute ischemic stroke. The hematocrit of acute clot (≤6 hours)
could be determined directly from QSM, but as the clots aged beyond the 6hour time point, knowledge of the relationship between R2* and QSM was
required to estimate hematocrit. Calcified and lipidic components were easily
identifiable in clot of any hematocrit and age through QSM and FF mapping,
respectively.
A blood-only thrombus phantom was scanned serially every 15 minutes over
the initial 6 hours post clot formation, and then intermittently thereafter for
up to 6 days. The 6-hour timeframe for more rigorous examination was
chosen because it is the commonly accepted treatment window for
thrombolytic and endovascular therapies for acute ischemic stroke;22 clots
examined over this period therefore give insight into the parameter values
expected in spontaneously formed, immediately occluding thrombi, as well as
how these values may evolve over the treatment window. R2* and QSM
values showed clear differences between the acute clots of different
hematocrit, indicating that even newly formed (and thus well-oxygenated)
clots may be differentiated by quantitative measurements of relaxation and
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susceptibility. In terms of the change in values over the 6-hour time period,
only a small increasing trend was observed in R2* while no trend was
observed in QSM values, implying little change in hemoglobin oxygenation
status. This is significant because it suggests that 6 hours may not be enough
time for thrombi to deoxygenate under ischemic conditions in vivo, and
therefore that thrombi that are deoxygenated upon clinical presentation
(indicated by the presence of a blooming artifact) have become so only after
considerable ageing at the site of thrombus formation, prior to embolization.
Observation of these same clots over the next 6 days of ageing, in contrast,
demonstrated considerable changes over the course of the experiment. Both
R2* and QSM values of clots increased in proportion to hematocrit over time,
reaching a plateau after 44 hours. Increasing R2* and QSM values within the
first few days of in vitro clot formation have been observed previously.17,18
RBC homeostasis is maintained through the metabolism of glucose;23 the
limited supply of naturally present glucose in vitro inevitably results in the
oxidative denaturation of oxyhemoglobin to paramagnetic deoxy- and
methemoglobin

forms,24

increasing

QSM

values,

and

consequently

heightening local field inhomogeneity and thereby increasing R2*. The delay
from clotting to when the rapid increase in R2* and QSM values was observed
is likely linked to the time taken for RBCs to exhaust the local glucose
supply. Because the clot R2* increase is driven primarily by a change in
magnetic susceptibility inhomogeneity, we would additionally expect the clots
with a similar heterogeneity of components (hematocrit between 40 to 60% in
this study) to demonstrate similar R2* values. Indeed, R2* values of the 40, 50
and 60% clots were comparable throughout the experiment, matching
previous measurements of deoxygenated blood.25 The observed decrease in
R2* observed at the 140 hour time point is likely due to a drop in R 2 that
occurs in excessively aged blood following lysis of the RBC membrane.25
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The quantitative imaging values derived in this in vitro study strongly
suggest that simultaneous measurement of R2* and QSM could be used to
infer hematocrit and age in clinical thrombi. Our results suggest that a
thrombus presenting with R2* and QSM values below 22 s-1 and 0.165 ppm,
respectively, can be considered to be acutely formed, and for these thrombi
hematocrit can be inferred directly from QSM. When R2* or QSM values are
above these thresholds, the thrombus can be assumed to be chronic and R2* or
QSM values alone will not be able to discriminate between a moderately aged
thrombus of high hematocrit and one of advanced aged with low hematocrit.
This study suggests that once a thrombus is identified as chronic, the
R2*/QSM ratio can be used to estimate hematocrit regardless of age. We
tested a number of parametric fitting methods to derive an equation relating
imaging values to hematocrit, including fitting to exponential and power
functions, as well as multiple linear regression; exponential fitting was
chosen because it provided the best performance, however no underlying
model was considered to justify this choice and it may not represent the best
possible method. Our hematocrit prediction accuracy of better than 10%
suggests that even clots of hematocrit between 40-60%, which showed similar
R2*, varied enough in their QS values to be differentiable by the R2*/QSM
ratio.
Of course, the derived values and relationships in this study of in vitro clots
may not be directly applicable to the clinic and must be validated in excised
human thrombi. Validation of the R2* and QSM thresholds for differentiating
between acute and chronic thrombus also needs to be performed in vivo,
however this is difficult to achieve as thrombus age is rarely known. It must
be further stressed that the age threshold of 6 hours defined here to
differentiate acute and chronic clot is unlikely to directly correspond to the
time period in which similar changes occur within thrombus imaging values

in vivo, as the rate of thrombus degradation is likely to differ and vary
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between subjects. Nonetheless, the evidence provided here strongly suggests
that R2* and QSM, measured simultaneously, are able to act as imaging
biomarkers that can identify thrombus age and hematocrit.
Additional clot phantoms were constructed to investigate the ability of the
quantitative maps to distinguish calcified and lipidic components within clots
of varied hematocrit and age, and to compare that to the ability of current
thrombus characterization methods. For acute clot, GRE magnitude images
have the ability to detect the calcified or lipidic components, but both give an
identical, low signal appearance; the GRE images are also unable to
discriminate between clots of different hematocrit. In contrast, lard shows
elevated FF compared to all clots and to calcium, while calcium shows unique
negative QSM values. In chronic clots, late-echo-magnitude images can
roughly tell apart clots of low vs. high hematocrit by the extent and degree of
signal loss, but this signal loss removes contrast between the clot and
additional components, eliminating the possibility of their detection. Applied
together, the quantitative R2*, QSM and FF maps distinguish between clots
of different hematocrit, as expected, while also providing the ability to
identify calcium and lipid components from the QSM and FF maps,
respectively.
Unavoidable imperfections of an in vitro clot phantom for representing
thrombi should be considered as limitations for transferring our findings to
future in vivo studies. Clots were formed statically through the addition of
thromboplastin, which has been shown to yield clots that are more
homogeneous than clinical thrombi,26 were assessed in a phantom that did
not incorporate the effects of blood flow, and were larger (10 mm diameter)
than those typically observed in vivo. During the first six hours, clots were
kept at room temperature within the MRI bore, which may have affected
parameter values. Chosen scan parameters and acquisition hardware were
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selected to be directly translatable to in vivo head imaging, and hence were
not optimized for in vitro samples. No histology was performed to confirm
that initial sample hematocrit was maintained throughout the experiment;
some retraction was observed in the 20 and 30% hematocrit clots and this
could have affected their true hematocrit, and measured imaging values, as
the experiment progressed. The lipid and calcium components do not
perfectly mimic in vivo thrombus cholesterol and calcifications. Cholesterol
within thromboemboli have been reported to consist of numerous small
crystals rather than a singular mass.27 Similarly, thrombus calcifications,
often derived from embolized calcifications within atherosclerotic plaque, are
composed primarily of calcium apatite,28 which is slightly less diamagnetic
than calcium carbonate and will therefore yield reduced QSM contrast. 29
Blood-related flow artifacts and signal contamination from the venous system
may affect the quantitative maps in vivo, particularly for QSM processing,30
but can be minimized through flow compensation and increasing spatial
resolution.31 Variable flip angle turbo spin echo sequences have also been
proposed as method for rapid, single-scan thrombus characterization,32 and
while they possess advantages of inherent black blood properties and variable
T1-weighting, these techniques provide only qualitative information and often
require contrast administration.33

2.5 Conclusion
The 10-echo GRE sequence and post-processing algorithms used in this study
generated accurate R2*, QSM and FF maps, which enabled quantitative
characterization of blood clot including the ability to estimate hematocrit and
age, while also distinguishing lipidic and calcified components. The protocol
is readily translatable to the emergency clinic as all quantitative maps were
generated from a single, contrast-free six-minute scan.
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2.7 Supplementary material
2.7.1 Methods
A calibration phantom was constructed to validate derived fat fraction (FF),
quantitative susceptibility mapping (QSM) and R2* maps, and included a
range of fat-water emulsions stabilized with agar, and aqueous gadolinium
(Gd) solutions. Samples with fat fractions of 0.1, 0.2 and 0.5 were prepared by
dispersing appropriate amounts of peanut oil into water with 43 mmol/L
sodium dodecyl sulfate (Sigma-Aldrich; St. Louis, MO). Samples were
emulsified using a sonifier (Branson S-450; Branson Ultrasonics; Danbury,
CT) for 2 minutes while heat was applied using a heat gun. Separately, a 4%
agar solution (Sigma-Aldrich; St. Louis, MO) was prepared and kept at 70°C
using a hot plate. The emulsified oil solution was added dropwise to the agar
solution with the mixture being heated and under sonication. An equivalent
volume of emulsified oil solution was added to the agar solution such that the
final concentration of agar was 2% in all cases. Separately, aqueous
Gadolinium solutions (Magnevist; Berlex Laboratories; Wayne, NJ) were
prepared at 0.125, 0.25, 0.5, 1, 1.5, 2 and 2.5% of the raw (0.5 mmol/mL Gd)
contrast agent, yielding magnetic susceptibility shifts of 0.20, 0.40, 0.81, 1.63,
2.45, 3.26 and 4.08 ppm at room temperature.1 Control samples of water (FF
= 0) and pure peanut oil (FF = 1) were also prepared. All samples were
transferred into 1 cm diameter, 5 mL polystyrene vials and placed vertically
inside an agar-filled container.
The calibration phantom was scanned with the same 10-echo GRE sequence
used for the thrombus phantoms. An additional scan was also performed
using the spoiled gradient-echo version of the IDEAL sequence to provide an
accepted-standard assessment of the fat fraction of the prepared samples.2
IDEAL FF maps were reconstructed on the scanner. Parameters for this scan
were as follows: TE1 = 1.60 ms, echo spacing = 0.86 ms, number of echoes = 9,
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repetition time = 13.6 ms, bandwidth = 142.86 kHz, flip angle = 5°, field of
view = 18 cm, matrix size = 160 x 160 x 20, slice thickness = 4 mm. No
averaging was performed.
Following

reconstruction

and

multi-parametric

map

generation,

segmentation of the FF calibration samples was accomplished by placing a 7mm diameter, 12-mm length cylinder across the middle slices of both the 10echo maps and the IDEAL FF maps. A 7-mm diameter circular cylindrical
region of interest (ROI) drawn across the central slice of the QSM map was
used for segmentation of the susceptibility calibration samples. Mean and
standard deviation values of the segmented pixels were recorded.

2.7.2 Results
Representative slices from FF, QSM and R2* maps and sample values derived
from the calibration phantoms are displayed in supplementary Figure 2-1.
Agreement was observed between the mean fat fraction values of the FF
calibration samples as determined by B0-NICE and IDEAL (supplementary
Figure 2-1D), though a slight overestimation of the B0-NICE FF is present
(max overestimation = 0.05) for the mixed fat-water emulsions as compared
to the IDEAL FF. This discrepancy is likely due to the flip-angle-dependent
T1 effect that biases scans with higher flip angles towards yielding larger FF
estimates (FA: 5 and 10º for IDEAL and B0-NICE, respectively).3 A linear
trend with a slope approaching unity (slope = 1.03, R2 = 0.99) was observed
between the expected and measured susceptibility values for the QSM
calibration samples (supplementary Figure 2-1E), indicating the QSM
method can perform accurate quantification of susceptibility across a broad
range of susceptibility shifts (up to 4.08 ppm). Lastly, a linear relationship
was observed between B0-NICE R2* and Gd concentration up to 12.5 mmol/L
(R2 = 0.99) within the QSM samples (supplementary Figure 2-1F).
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Supplementary Figure 2-1: Central coronal slices of the (A) B0-NICE fat
fraction (FF) [0, 1], (B) MEDI quantitative susceptibility mapping (QSM) [1.25 ppm, 3.25 ppm] and (c) B0-NICE R2* [0 s-1, 350 s-1] maps. For the FF
phantom (A) the nominal fat fraction of each vial is identified; unlabeled vials
contain both fat and Gadolinium (Gd) and were not analyzed. For the
susceptibility phantom (B, C), labels show Gd concentration (mM); unlabeled
vials contain oil/water emulsions. (D) B0-NICE FF plotted against FF
measured using the IDEAL sequence; (E) measured QSM against expected
sample susceptibility; (F) B0-NICE-derived R2* is plotted against Gd
concentration. Error bars represent the standard deviation of all pixels
within each region of interest. Note that the oil vial displays an artifactual
diamagnetic susceptibility on the QSM map because of the varying fat-water
phase shifts in the processed echoes.
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CHAPTER 3

Quantitative prediction of stroke thrombus
erythrocyte content from ex vivo
multiparametric MRI using deep learning

3.1 Introduction
The desired outcome of acute ischemic stroke (AIS) treatment is to achieve
rapid recanalization, and yet despite improvements in thrombolytic agents
and reperfusion devices, successful recanalization is not achieved in
approximately 25% of patients.1 Thrombus composition has emerged as a
significant factor influencing the success of AIS treatment.2 Particularly, the
proportion of thrombus erythrocyte (red blood cell (RBC)) content has been
linked to the efficacy of both recombinant tissue plasminogen activator (rtPA)
and endovascular thrombectomy (EVT) therapies.3,4 Non-invasive prediction
of thrombus RBC content prior to acute treatment would provide a valuable
tool for stroke interventionalists, and has been sought through medical
imaging.
The presence of qualitative susceptibility vessel and hyperdense artery signs
in MR and CT imaging, respectively, have each demonstrated capability for
characterizing RBC content categorically, distinguishing between groups
such as RBC vs. fibrin-dominant.4,5 However, such signs have proven
inconsistent in their predictions of thrombus amenability to rtPA and EVT
therapies6

and

have

noted

issues

with

inter-scanner

variability.7

Quantitative imaging techniques utilizing MR R2*, quantitative susceptibility
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mapping (QSM) values, or CT Hounsfield units have shown promise for more
robust, quantitative prediction of RBC content,3,8,9 as well as for predicting
efficacy of rtPA and EVT therapies.10,11 However, these techniques remain
limited by their use of a single imaging value or metric to represent entire
thrombi. Histological studies have consistently demonstrated that thrombi
are heterogeneous and complex in structure,12 and that complexities such as
the distribution of fibrin and RBC components have a material impact on
treatment efficacy.13
To account for these structural complexities, machine learning techniques
have recently started being applied towards thrombus analysis. Past
techniques generated models from MR or CT imaging texture features, and
have demonstrated sensitivity to clot RBC content in vitro

14,15

as well as an

ability to predict clinical features such as response to rtPA.16 Concerns linger
however about the reproducibility of calculated texture futures and the
generalizability of these techniques.17 Further still, machine learning
techniques are limited by the need to initially handpick extractable features
for study; the histomorphological basis underlying the distinguishing ability
of imaging texture features is an ongoing area of research.18
Deep learning neural networks provide a complimentary tool to machine
learning techniques with the primary advantage being that featurization, the
process of turning raw signal into a modellable predictor, is fully automated.
Convolutional neural networks (CNNs) have been successfully applied
towards medical imaging problems where relevant imaging features are
difficult to define, such as for predicting brain age and aneurysm
stability.19,20 CNNs have also demonstrated utility in AIS, in areas such as
predicting ischemic tissue fate and thrombus detection.21,22 However, CNNs
have not yet been applied towards analysis of the thrombus itself. In this
study, we assess the capability of CNNs for prediction of stroke thrombus
RBC content using MR images. Specifically, we trained a CNN on
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quantitative MR R2*, QSM maps as well as T2*-weighted gradient echo (GRE)
images of ex vivo AIS thrombi retrieved by EVT, investigated the use of data
augmentation

techniques

to

improve

network

performance,

and

quantitatively assessed the accuracy of the trained CNN for numerical
prediction of RBC content.
The methods for prediction of RBC content directly from mean clot R2* and
QSM, described in Chapter 2, were tested on the human thrombi included in
this study but ultimately failed to produce accurate predictions. Thrombus
RBC content was consistently underestimated and a Bland-Altman plot of
these predictions is shown in this chapter’s supplementary material
(supplementary Figure 3-1). More advanced image analysis techniques were
necessitated, and deep learning was chosen because of its ability to interpret
multiple image types simultaneously, a feature found to be important in
Chapter 2 wherein the relationship between clot R2* and QSM was used to
derive RBC predictions.

3.2 Materials and methods
3.2.1 Thrombus collection and storage
Institutional research ethics board approval was obtained for this study. AIS
patients who were treated with EVT at the local stroke centre were
consecutively enrolled between the periods of February 2016 to November
2017. Retrieved thrombi were stored and transferred to an attached
institution for ex vivo MR imaging and histological analysis. Patients were
excluded if insufficient thrombus material was retrieved for study (>2 mm in
all dimensions) or if younger than 18 years old. Informed consent was
obtained following the EVT procedure and samples were discarded if consent
was refused.
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A total of 109 thrombi were collected from 65 AIS patients. Thrombi were
stored inside a 150 mL plastic jar containing a non-adherent pad (Telfa;
Covidien, Mansfield, MA) wetted with heparinized saline to retain moisture.
Those retrieved during the daytime were kept at room temperature and
scanned within 6 hours of retrieval, otherwise thrombi were kept inside a
refrigerator overnight until the following workday. It was observed that
thrombi which had been placed in a fridge and stored overnight had
significantly lower R2* and QSM values than those kept at room temperature
(supplementary Figure 3-2). Due to this effect, only those stored at room
temperature were histologically analyzed and included in the study; final
sample size was 48 thrombi. Clinical details associated with each group of
stored thrombi are listed in Table 3-1.
Table 3-1: Clinical details of the patient cohort for each thrombus storage
group
Storage type
Room temperature (n = 31)
Refrigerator (n = 32)
Age (mean ± SD)
67 ± 17
70 ± 12*
Sex, female
14 (45%)
13 (43%)*
Number of thrombi
48
61
Etiology
Large artery atherosclerosis
6 (20%)
3 (9%)
Cardioembolism
21 (68%)
22 (69%)
Dissection
2 (6%)
1 (3%)
Undetermined
2 (6%)
6 (19%)
Occlusion site
MCA
25 (81%)
27 (85%)
ICA
1 (3%)
3 (9%)
Vertebrobasilar
5 (16%)
2 (6%)
EVT technique
Stent
26 (84%)
29 (91%)
Aspiration
5 (16%)
3 (9%)
IV rtPA
15 (48%)
11 (34%)
*n=2 missing data
MCA, middle cerebral artery; ICA, internal carotid artery; IV rtPA,
intravenous recombinant tissue plasminogen activator.

80

3.2.2 Ex vivo thrombus imaging
Following storage, the retrieved thrombi were scanned inside 1 cm diameter
polystyrene vials containing porcine plasma and vertically inserted into a 15cm diameter agar-filled container.8 A small agar plug was added to the
bottom of the vials so that the thrombi sat flat on their surface. When more
than one specimen was obtained from a single participant, thrombus pieces
were scanned in individual tubes and analyzed separately. Scanning was
performed at 3.0 T using a whole-body MRI scanner (GE 750; GE Medical
Systems, Milwaukee, WI) with a 32-channel receive head coil. Scans were
acquired using a 3D multi-echo bipolar GRE sequence designed for clinical
imaging in vivo;23 the sequence includes two 5-echo trains: the first train was
optimized for chemical shift imaging (first echo time (TE) = 3.20 ms, echo
spacing = 1.46 ms); the second train was optimized to highlight susceptibilityrelated contrast (first TE = 16.75 ms, echo spacing = 7.15 ms). The remaining
scan parameters were repetition time = 47.6 ms, bandwidth = 142.86 kHz,
flip angle = 10°; field of view = 18 cm; matrix size = 192 × 192 × 36, for a final
voxel dimension of 0.94 × 0.94 × 1.0 mm3. Total acquisition time was 5
minutes 33 seconds. Balanced steady-state gradient echo (FIESTA-C) images
with identical resolution and bandwidth were also acquired to facilitate
thrombus segmentation (TE = 3 ms, TR: 6.1 ms, flip angle: 40°, phase cycles =
4, scan time = 2 min 47 sec). All scans were acquired in the coronal plane,
with the phantom laying flat along the MR table and vials aligned
perpendicular to B0. Thrombi sat horizontal relative to the long axis of the
vials, and were also aligned perpendicular to B0.

3.2.3 Image processing
Image reconstruction was performed in Matlab (Matlab R2019a; Mathworks,
Natick, MA) using the Orchestra Software Development Kit (GE Healthcare;
Milwaukee, WI). Complex channel combination was performed using singular
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value decomposition from which GRE magnitude images were derived. R2*
and QSM maps were generated using the B0-NICE and MEDI QSM
algorithms.24,25 Thrombi were segmented from the FIESTA-C images, which
were inherently co-registered with the GRE sequence. Thrombus R2*, QSM
and GRE magnitude pixel values were each separately z-score normalized
according to distributions derived from all segmented thrombi.

3.2.4 Histological analysis
Immediately following imaging, thrombi were formalin fixed, embedded in
paraffin and arranged for sectioning along the MR slice-encoding direction.
Thrombi were sectioned at 5 μm thickness and stained with hematoxylin &
eosin. The first 14 were sectioned in 4 evenly spaced regions throughout the
thrombi (3 – 4 mm thick on average); it was observed that RBC content
varied minimally between thrombus slices, concurring with the findings of
Staessens et al.,26 so remaining thrombi were sectioned only once through the
middle of each sample (supplementary Figure 3-3). Stained slides were
scanned at ×40 magnification. The color segmentation plugin (EPFL,
Lausanne, Switzerland) in ImageJ (National Institutes of Health, Bethesda,
MD) with post-processing correction for outlying pixels in Matlab was used to
quantify thrombus RBC percentage by area.

3.2.5 Deep learning network
3.2.5.1 Network architecture
Using the acquired thrombus MR images, a convolutional neural network
(CNN) was trained in Matlab to predict histological RBC content. Twodimensional slices of the segmented, normalized R2*, QSM and late echo GRE
magnitude images (TE = 31 ms) were fed into the network as 3-channel RGB
images; each image was 49 × 56 pixels in size. 188 segmented 3-channel slices
were available from the 48 analyzed thrombi for training and testing. It was
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assumed that all slices from a single thrombus had the same RBC content
derived from histology. The network architecture – shown in the schematic
illustration in Figure 3-1 – consisted of 2 repeated blocks of a convolutional
layer (3×3, stride of 1, zero-padded), a rectified linear unit (ReLU) and an
average-pooling layer (2×2, stride of 1), followed by a final convolutional layer
and ReLU layer, a dropout layer and a fully connected layer with a single
output connected to the regression layer. The number of feature channels for
each of the convolutional layers was set to 16, 16, and 32, respectively. The
Adam optimizer was used with an initial learning rate of 0.001; L2
regularization was implemented with a λ of 0.01. Network parameter weights
were trained by minimizing the half mean squared error using stochastic
gradient decent.

Figure 3-1: Schematic diagram of the CNN. Three-dimensional RGB images
consisting of segmented, normalized thrombus R2*, QSM and GRE magnitude
images are fed into a network consisting of 3 convolutions layers with
average pooling layers in between and a dropout layer at the end, before a
final fully-connected layer. Padding is employed to retain image size in the
convolutional layers.

3.2.5.2 Data augmentation
Given the relatively small thrombus MR slice dataset available for network
evaluation, overfitting of the training data was a concern. In light of this,
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image data augmentation was employed and implemented to various degrees
in order to observe its effect on network performance. Augmentation
consisted of three distinct components: input sampling equalization, image
transformation, and dataset duplication.
For input sampling equalization, oversampling of training data was
performed to equalize the distribution of thrombus RBC content. Thrombus
MR slices randomly selected to be in the training set were first binned based
on RBC content in 5% intervals, and underrepresented bins had all slices
repeatedly sampled until their count equaled the nearest integer multiple of
the bins original slice count less than or equal to the most represented bin.
This resampling strategy is similar to the class-aware sampling strategy that
has previously been employed on categorical data.27 A representative training
set RBC distribution before and after input sampling equalization is shown in
Figure 3-2.

Figure 3-2: Representative training set thrombus RBC content distribution
(A) before and (B) after input sampling equalization.
For image transformation, a group of geometric transformations were
randomly applied to both the training and testing datasets. Random
transformations were performed within predefined ranges: rotations between
-90 to 90°, integer vertical and horizontal translations up to 5 pixels,

84
reflections across the X and Y axis, scaling between 0.7 to 1.3 and shearing
between -30 to 50°. An example 3-channel thrombus input slice before and
after transformation, with its base images, is shown in Figure 3-3.
Finally, for dataset duplication the entire training set was copied at up to a
×5 multiple prior to network training. When employed, it was implemented
after input sampling equalization and before image transformation, so that
all slices inputted into the network were unique.

Figure 3-3: An example thrombus (A) R2*, (B) QSM, (C) GRE magnitude
image slice, shown inside its scanning vial, along with the (D) FIESTA-C
image used for segmentation. The resulting normalized, segmented thrombus
RGB image slice used as CNN input is shown (E) before and (F) after random
image transformation. R2*, QSM and GRE magnitude pixel values represent
the red, green and blue image color channels, respectively.

3.2.5.3 Network evaluation
The network was evaluated using 8-fold cross validation, where the mean
accuracy (proportion of predictions within 10% of histology), absolute error
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and root mean square error (RMSE) across all folds were used for network
assessment. Care was taken to ensure no slices associated with the same
thrombus were mixed between the training and testing subsets within each
cross-validation fold. The network was separately trained and evaluated with
8 different data augmentation strategies: no augmentation, input sampling
equalization or image transformation only, input sampling equalization and
image

transformation,

and

input

sampling

equalization

and

image

transformation with dataset duplication of ×2 – ×5 multiples. Across each of
these network implementations hyperparameters sensitive to the size of the
input dataset were iteratively tested: training epochs were varied between 4
to 9 in steps of 1, batch size was varied between 6, 8 and 12, and dropout was
varied between 0 to 0.4 in steps of 0.1. Results from the best network
iteration associated with each data augmentation strategy were recorded.
The training time for a single 8-fold cross validation experiment was as fast
as 86 seconds for the unaugmented dataset to as long as 32 minutes for the
×5 duplicated, equalized, transformed dataset on a dual-core CPU (Intel Core
i5) with 16 Gb of RAM.

3.2.6 Statistical analysis
In addition to accuracy, absolute error and RMSE, network performance was
also evaluated as the correlation between histological and predicted RBC
content, using Pearson’s r and slope. Statistical analysis was performed using
GraphPad Prism (v8.2.1; GraphPad Software, La Jolla, CA).

3.3 Results
The mean thrombus RBC content determined from histological analysis was
39 ± 13% (median: 38%; interquartile range: 30 – 49%; min: 12%, max: 61%).
Results

from

the

best-performing

network

iterations

for

predicting
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histological RBC content at each level of data augmentation are shown in
Table 3-2.
In general, the networks correctly predicted thrombus RBC content, with an
accuracy and error that improved as more extensive augmentation was
performed, as expected. In particular, a large improvement in network
accuracy was seen after both input sampling equalization and image
transformation were applied, increasing it from 66% to approximately 72%.
With both equalization and transformation applied, increased training set
duplication did not further increase accuracy but minorly improved RMSE
from 10.3% to approximately 9.8%. For reference, a naive prediction
(prediction of the overall mean histological RBC percentage for all thrombi)
would produce an accuracy, absolute error and RMSE of 54.2, 10.5 and
12.4%, respectively.
Table 3-2: Performance of the CNN for thrombus histological RBC content prediction
(T/F: true/false; ×n: training set duplication by a factor of n)
Input
Image
Training set Accuracy Absolute RMSE
r
Slope
equalization transformation duplication
(%)
error (%)
(%)
F
F
×1
66.1
8.26
9.83
0.51
0.25
T
F
×1
66.5
8.22
10.06
0.40
0.22
F
T
×1
67.5
8.06
10.03
0.27
0.08
T
T
×1
73.9
7.99
10.33
0.46
0.24
T
T
×2
72.1
8.07
9.85
0.53
0.29
T
T
×3
71.0
7.85
9.91
0.53
0.33
T
T
×4
72.2
8.01
9.83
0.55
0.32
T
T
×5
72.2
8.15
9.82
0.57
0.34

Regression curves plotting the median predicted thrombus RBC content
against that determined through histology were used to determine
correlation coefficients and linear regression slopes, and are listed for each
best-performing network iteration in Table 3-2. Here, input equalization and
image transformation applied individually decreased correlation and
regression slopes compared to the unmodified dataset, but with both applied
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training set duplication improved correlation and slope up to 0.57 and 0.34,
respectively, in the ×5 duplicated dataset.
Regression plots from the network iterations with the best accuracy, absolute
error and RMSE (bold in Table 3-2) are shown in Figures 3-4A – C. Despite
the highest accuracy achieved being the network iteration trained on
augmented data at only ×1 duplication, its distribution of RBC content
predictions is noticeably flatter than those trained on larger datasets,
implying the network learned to make predictions only within a narrow
range of RBC content. This yields poor prediction accuracy in thrombi with
very high or low RBC content, resulting in a high RMSE value of 10.33%, the
largest in Table 3-2. RMSE weighs large individual residuals more heavily
than absolute error; the discrepancy between this network iteration’s high
accuracy and poor RMSE underscores the need to consider multiple
descriptive statistics when evaluating network ability.
In general, all networks predicted RBC content more accurately in thrombi
whose histological values were closer to the mean than in those further
outside it. When the thrombi included in the regression plots are limited to a
narrower range of RBC content closer to the mean (20 – 45%), slopes of the
prediction curves increase substantially, reaching up to 0.89 in the network
trained on the ×5 duplicated dataset (Figures 3-4D – F). Network
performance results corresponding to this trimmed subset of predictions are
listed in Table 3-3. In this subset network performance is greatly improved
compared to that achieved on the entire dataset, suggesting that this network
may be capable of producing more accurate RBC content predictions when
trained on larger data sets, but is hindered here by the limited data available
for thrombi with less common RBC content.
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Figure 3-4: Linear regression plots of the CNN predicted thrombus RBC
content against the histological value for best-performing network iterations
on the equalized, transformed dataset with (A) ×1, (B) ×3, and (C) ×5
duplication, respectively. Plotted are the median predictions from all MR
slices available for each thrombus. These same predictions replotted with
only thrombi with histological RBC content between 20 – 45% are shown in
(D), (E) and (F), respectively.
Table 3-3: Performance of the CNN for thrombus histological RBC content prediction
when limited to thrombi between 20 – 45% RBC content (T/F: true/false; ×n: training
set duplication by a factor of n)
Input
Image
Training set Accuracy Absolute RMSE
r
Slope
equalization transformation duplication
(%)
error (%)
(%)
F
F
×1
77.8
5.51
7.38
0.48
0.44
T
F
×1
77.8
6.82
7.87
0.52
0.59
F
T
×1
59.3
8.42
10.69
0.08
0.03
T
T
×1
92.6
4.07
5.64
0.73
0.76
T
T
×2
88.9
4.48
5.49
0.73
0.8
T
T
×3
88.9
4.31
5.87
0.71
0.84
T
T
×4
92.6
4.77
6.01
0.68
0.76
T
T
×5
96.3
4.65
5.58
0.76
0.89
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3.4 Discussion
In order to evaluate the ability of CNNs to predict AIS thrombus RBC
content, we trained a 3-layer CNN on segmented thrombus MR images
acquired ex vivo. Even with a modest dataset of 48 thrombi (188 slices) for
training, this study demonstrates that a CNN is capable of predicting RBC
content in AIS thrombi solely from MR images with an average accuracy
above 70%. This was achieved by using data augmentation strategies
designed to increase the effective size of the dataset and reduce overfitting. In
spite of augmentation, predictions of RBC content in thrombi with
histological values closer to the mean were more accurate than those outside
of it, suggesting the CNN did not have sufficient training data available to
learn to accurately predict across the full range of thrombus RBC content.
Our CNN was trained on ex vivo images of retrieved AIS thrombi. We chose
to perform this study ex vivo to allow easier patient recruitment while
minimizing patient burden. Our ex vivo imaging protocol is similar to that of
previous in vitro blood clot imaging experiments,8,9 and ex vivo thrombus MR
microscopy studies.28 However, unlike previous ex vivo thrombus imaging
studies, we noted a significant storage effect on the MR values of retrieved
thrombi. Stroke thrombi retrieved at night were stored in a refrigerator until
they could be scanned the next available workday, and these thrombi had
significantly lower R2* and QSM values than those scanned within the same
day and kept at room temperature. Cold temperatures increase hemoglobin’s
oxygen affinity, which may have led to thrombus reoxygenation resulting in
reduced MR R2* and QSM values.29 An explicit examination into the effect of
various storage conditions on the MR imaging values of stroke thrombi is
outside the scope of this report and warrants closer study.
Due to the abovementioned storage effect limiting our dataset to just 188
segmented thrombus slices available for training and testing, we investigated
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the use of data augmentation techniques for improving CNN performance.
Data augmentation is a widely used method for increasing the diversity and
depth of input data to improve deep learning network performance, largely by
reducing network overfitting of training data.30 Here, we oversampled our
dataset such that thrombi of all RBC contents were equally represented in
the training dataset. Input sampling equalization through oversampling is
one of the most common methods for dealing with class imbalance in deep
learning, and forces the network to learn features relevant to the entire
dataset rather than just the most common entries.31 Additionally, we applied
a multitude of random image transformations to our dataset, which has
shown to outperform single transformations applied on their own.32,33 We
used geometric transformations specifically to avoid the network focusing on
irrelevant characteristics of the thrombi such as orientation and shape, the
latter of which can be altered during thrombectomy. Finally, we increased the
size of the training dataset directly by duplicating the entire set prior to
image transformation, which has proven to improve the performance of CNNs
trained on small datasets.33 We applied these data augmentation techniques
sequentially, and it is notable that the largest improvements in network
performance relative to the original, unaugmented dataset were observed
only after input equalization and image transformation were applied
together. This highlights the benefit of having both balanced and varied
datasets when training a CNN for thrombus RBC content prediction.
With the use of data augmentation techniques, the CNN was able to learn to
predict RBC content in thrombi with approximately 72% accuracy and 8%
mean absolute error. It is difficult to precisely define what level of accuracy
would be required for a thrombus RBC content predictor to be clinically
useful. Studies examining the relationship between histological thrombus
RBC content and successful recanalization following EVT have found an
average RBC content difference of approximately 17%,3,34 while in one study
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the difference between rtPA-resistant thrombi and those untreated was
approximately 10%.35 A mean absolute error less than the average difference
between these clinical groups suggests that even a CNN trained on a small
dataset has the potential to be clinically useful, particularly considering that
an improvement in the network’s performance would reasonably be expected
if trained directly for these tasks.
Despite the respectable overall accuracy, weaknesses were apparent in that
the predictive ability of the CNN was noticeably poorer for thrombi with RBC
content outside the mean histological value. We showed regressive plots of
the most accurate portion of the thrombus predictions to demonstrate the
CNNs potential capability when given a richer dataset, but the cut-offs to
where CNN accuracy decreased are instructive. RBC content prediction
accuracy was poor in thrombi with a less than 20% or greater than 45% RBC
percentage. Just 4 thrombi had RBC content less than 20%, so it is
reasonable that the CNN would perform poorly in this subset due to a lack of
representative data, even after input sampling equalization. In contrast
however, 17 of the 48 thrombi had an RBC content greater than 45%. This
bound could instead be reflective of the fact that blood clots with 40-60% RBC
content have similar R2* rates due to their similarly heterogeneous
composition; this may have reduced their distinguishability within the CNN.8
While it is expected that the CNN performance would improve with
additional thrombi available for study, this suggests that predicting RBC
content of thrombi in the range of 40-60% in particular may be more
challenging. Studies have not demonstrated a benefit, however, for finely
differentiating between RBC-rich thrombi; current research suggests that all
thrombi

in

this

RBC

content

range

would

likely

yield

successful

recanalization when treated with EVT, for example.3,34
This study has a number of limitations. We made the assumption that all 2D
imaging slices from same thrombus had an RBC content equal to the single
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value derived from histology. While there is evidence suggesting that
composition varies little throughout thrombi,26 slight variations in RBC
content across each MR slice would limit the CNN accuracy. We used an 8fold cross validation to evaluate our network instead of defining a distinct
testing set. Doing so means the generalizability of the network maybe be
overestimated, but cross-validation has been recommended for datasets that
are too small to include a test set of meaningful size.36 Finally, we performed
our imaging ex vivo after thrombi had been retrieved through EVT. This
allowed us to perform our imaging study without impacting the course of
patient treatment, but introduces potential confounding factors which could
affect imaging results such as the effect of thrombus storage outside the body,
potential alterations in the thrombus structure during the EVT procedure,
and differences in temperature and field inhomogeneity relative to in vivo
imaging. Chosen scan parameters and acquisition hardware were selected to
be directly translatable to in vivo head imaging, and hence were not
optimized for ex vivo samples. Performing the study ex vivo also meant that
the samples were limited to stroke thrombi that were retrievable by EVT and
that did not resolve following rtPA administration. While evaluation of this
technique in vivo with a larger sample size is ultimately required to
demonstrate utility in AIS patients, the results presented here suggest CNNs
are capable of predicting stroke thrombus RBC content using MR images.

3.5 Conclusion
In this study, we demonstrated that a 3-layer CNN is capable of RBC content
prediction in AIS thrombi using ex vivo R2*, QSM and late-echo GRE
magnitude MR images. We improved CNN performance by employing data
augmentation involving equalized input sampling, geometric transformation
and duplication of the dataset. Our trained network predicted thrombus RBC
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content with an overall accuracy of approximately 72% and an absolute error
of approximately 8%. The rapid imaging protocol and straightforward
network design used in this study enables ready translation towards in vivo
imaging for prediction of thrombus RBC content in AIS patients.
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3.7 Supplementary material

Supplementary Figure 3-1: Bland-Altman plot showing the difference
between thrombus histological RBC content and that predicted through mean
R2* and QSM values using the methods described in Chapter 2. Predicted
RBC content consistently underestimated the histological values, yielding a
mean error of 20 ± 22% and a mean absolute error of 25 ± 16%.

Supplementary Figure 3-2: Effect of storage method and time between
thrombus retrieval and MR imaging on mean thrombus (A) R2* and (B) QSM
values. Thrombi were either stored at room temperature and scanned within
the same workday, or stored in a fridge until the next available workday.
Two-tailed T-tests between the two groups R2* and QSM values yielded
significant differences with p = 0.0005 and p = 0.02, respectively.
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Supplementary Figure 3-3: Thrombus multi-section histological results.
Mean RBC content is shown at 3 or 4 evenly spaced intervals through the
retrieved stroke thrombi. Red dots indicate the average RBC content values
at each slice for all thrombi.
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CHAPTER 4

Ex vivo thrombus MR imaging features and
patient clinical data enable prediction of acute
ischemic stroke etiology

4.1 Introduction
Determination of acute ischemic stroke etiology is a critical component of
reducing stroke recurrence risk, but in current clinical practice etiology
remains undetermined in approximately one third of cases.1 Histological
analysis of retrieved thrombi has demonstrated that thrombus composition,
particularly red blood cell (RBC) content, can be used to differentiate between
etiologies, but histological analysis is impractical as a rapid diagnostic tool. 2-4
Medical imaging offers the potential to non-invasively infer information,
including but not limited to thrombus composition, supporting the prompt
determination of stroke etiology.
Magnetic resonance (MR) imaging and computed tomography (CT) have each
demonstrated sensitivity to thrombus RBC content, through the qualitative
susceptibility vessel and hyperdense artery signs, respectively.5-7 However, a
recent meta-analysis found no significant association between these signs
and stroke etiology, and an analysis of the THRACE randomized controlled
trial found the diagnostic accuracy of the susceptibility vessel sign for
etiology determination to be just 49%.8,9 Quantitative MR and CT techniques,
in particular those measuring R2* and quantitative susceptibility mapping
(QSM) or Hounsfield units, respectively, have demonstrated ability to
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quantitatively assess the RBC content of prepared blood clots in vitro,10-13 but
these values too have failed to produce significant associations with stroke
etiology

in vivo.14,15 Past imaging approaches for stroke thrombus

characterization may be limited by their use of a single imaging value or
metric to represent entire thrombi, which is discordant with histological
studies demonstrating that the structure of stroke thrombi is complex and
heterogeneous.16
Radiomics is the conversion of medical images to mineable high-dimensional
data, from which quantitative imaging features can be derived. 17 Such
imaging features may be used as input into machine learning algorithms,
enabling analysis of information within contexts beyond that perceptible to
the human eye. Imaging features related to object texture, in particular, have
demonstrated aptitude for characterization of tissues with heterogeneous
structure, such as tumours.18-21 In the field of stroke imaging, texture
features have been used to predict post-stroke impairment and in lesion
detection.22,23 They have also been applied towards the characterization of
thrombi, showing sensitivity to RBC content in vitro on R2* maps as well as
for predicting response to intravenous recombinant tissue plasminogen
activator (rtPA) and endovascular therapies (EVT) in stroke thrombi in vivo
on non-contrast CT.24-26 However, texture features have not been previously
applied in stroke thrombi towards the determination of etiology.
In this study, we evaluate the ability of radiomics features applied to
quantitative MR images of retrieved ischemic stroke thrombi, in combination
with patient clinical data, for the prediction of stroke etiology using machine
learning. Specifically, we extract image size, shape and texture features from

ex vivo thrombus R2*, QSM and fat fraction (FF) maps, and mine clinical
characteristics of the stroke patients, to train random forest classifiers which
discriminate between cardioembolic (CE) and large artery atherosclerotic
(LAA) stroke.
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In contrast to the deep learning methods described in Chapter 3, machine
learning was used in this study because it more readily allows the derivation
of models that incorporate thrombus MR imaging and patient clinical data
together.

4.2 Materials and methods
4.2.1 Study design and inclusion criteria
Institutional research ethics board approval was obtained for this study.
Acute ischemic stroke patients treated with EVT at London Health Sciences
Centre University Campus were consecutively enrolled between the periods
of February 2016 to November 2017 and October 2019 to March 2020. Data
from the earlier (training) cohort were used to select relevant imaging and
clinical features and train the machine learning models, while data from the
later (validation) cohort were used to evaluate their performance against an
independent dataset. Patients or their substitute decision makers were made
aware of the study at the time consent was given for EVT, and gave informed
consent after the procedure was completed and a thrombus was retrieved.
EVT was performed using a stentriever or Penumbra System® at the
interventionalist’s discretion. Inclusion criteria for the study were age greater
than 18 years old, CE or LAA stroke etiology, no recent prior stroke and
sufficient thrombus material retrieved for study (>2 mm in all dimensions).
Thrombi were saved upon retrieval for subsequent MR imaging.
Patient clinical data was collected and used as additional input in the
machine learning models. Clinical history parameters obtained for the study
included:

age,

gender,

prior

stroke

history,

hypertension,

diabetes,

hyperlipidemia, coronary artery disease, cardiac valve disease, peripheral
artery disease, smoking history, prior deep vein thrombosis, chronic kidney
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disease,

obesity,

prior

infections,

active

cancer,

antiplatelet

usage,

anticoagulant usage, and stroke etiology as determined by the Trial of ORG
10172 in Acute Stroke Treatment (TOAST) criteria.27 Procedural parameters
included: rtPA administration, intracerebral hemorrhage, stroke recurrence,
final TICI score, arrival NIHSS, occlusion side, occlusion location, number of
EVT

passes, and

EVT

duration.

Blood work

parameters included:

triglycerides, cholesterol, high-density lipoprotein, low-density lipoprotein,
glucose, leukocytes, and troponin.
With the exception of stroke etiology, all clinical parameters included in this
study are obtainable within a few days of acute stroke; this was to ensure
that derived models are applicable within the acute to subacute stage of
stroke treatment. A summary of basic clinical data for both the training and
validation cohorts is given in Table 4-1.

4.2.2 Thrombus storage and imaging
Thrombi retrieved in the training cohort were stored inside a 150 mL plastic
jar containing a gauze pad (TELFA™) wetted with heparinized saline to
retain moisture. Those retrieved during the daytime were kept at room
temperature and scanned within 6 hours of retrieval; otherwise thrombi were
kept in a refrigerator until the following workday. All thrombi retrieved in
the validation cohort were kept at room temperature and scanned within 6
hours of retrieval.

104
Table 4-1: Summary of clinical details for each patient cohort
Patient cohort
Training (n = 49)
Validation (n = 9)
Age (mean ± SD)
72 ± 15
74 ± 17
Sex, female
20 (41%)
4 (44%)
Etiology
Large artery atherosclerosis
8 (16%)
4 (44%)
Cardioembolism
41 (84%)
5 (56%)
Number of thrombi
76
15
Large artery atherosclerosis
15 (20%)
7 (47%)
Cardioembolism
61 (80%)
8 (53%)
IV tPA
18 (37%)
4 (44%)
Occlusion site
ICA
3 (7%)
0 (0%)
ICA + MCA M1
9 (18%)
3 (33%)
MCA M1
20 (41%)
4 (44%)
MCA M1 + M2
3 (6%)
1 (11%)
MCA M2
9 (18%)
1 (11%)
Vertebrobasilar
5 (10%)
0 (0%)
EVT technique
Stent
43 (88%)
9 (100%)
Aspiration
6 (12%)
0 (0%)
Prior stroke
10 (20%)
2 (22%)
Hypertension
34 (69%)
7 (78%)
Diabetes
6 (12%)
3 (33%)
Obesity
2 (4%)
0 (0%)
Smoking, past 5 years
5 (10%)
4 (44%)
Hyperlipidemia
23 (47%)
7 (78%)
Coronary artery disease
10 (20%)
4 (44%)
Cardiac valve disease
4 (8%)
1 (11%)
Chronic kidney disease
0 (0%)
2 (2%)
Abbreviations: IV tPA, intravenous recombinant tissue plasminogen
activator; MCA, middle cerebral artery; ICA, internal carotid artery.
Thrombi were scanned inside 1 cm diameter polystyrene vials containing
porcine plasma, inserted vertically into an agar-filled container. A small agar
plug was placed at the bottom of the vials so that the thrombi sat flat on their
surface. When more than one thrombus specimen was obtained from a
patient, each piece was scanned in a separate vial and analyzed individually.
Scanning was performed at 3.0 T using a whole-body MRI scanner (GE 750,
GE Medical Systems, Milwaukee, WI) with a 32-channel receive head coil.
Scans were acquired using a 3D multi-echo bipolar GRE sequence designed
for clinical imaging in vivo;28 the sequence includes two 5-echo trains: the
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first train was optimized for chemical shift imaging (first echo time (TE) =
3.20 ms, echo spacing = 1.46 ms); the second train was optimized to highlight
susceptibility-related contrast (first TE = 16.75 ms, echo spacing = 7.15 ms).
The remaining scan parameters were repetition time = 47.6 ms, bandwidth =
142.86 kHz, flip angle = 10°; field of view = 18 cm; matrix size = 192 × 192 ×
36, for a final voxel size of 0.94 × 0.94 × 1.0 mm3. Total acquisition time was 5
minutes 33 seconds. A FIESTA-C sequence with identical resolution and
bandwidth was also acquired to facilitate thrombus segmentation (TE = 3 ms,
TR: 6.1 ms, flip angle: 40°, phase cycles = 4, scan time = 2 min 47 sec). All
scans were acquired in the coronal plane, with the phantom lying flat along
the MR table and vials aligned perpendicular to B0. Thrombi sat horizontal
relative to the long axis of the vials, and were also aligned perpendicular to
B0.

4.2.3 Image post processing
Raw image data were reconstructed in Matlab (Matlab 8 R2015a;
Mathworks, Natick, MA) using the Orchestra Software Development Kit (GE
Healthcare; Milwaukee, WI). Complex channel combination was performed
using singular value decomposition and phase errors resulting from the
bipolar acquisition were removed.29 R2*, FF and QSM maps were generated
using the B0-NICE and MEDI QSM algorithms.29,30 Thrombi were segmented
semi-automatically on the FIESTA-C images, which are naturally coregistered with the quantitative maps.

4.2.4 Radiomics analysis and machine learning models
A radiomics and machine learning Matlab method previously developed by
Vallières et al. was adapted for use in this study.20 The code includes a
feature selection portion and a random forest model derivation portion using
the selected features. Three random forest classifier models were prepared;
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one each using thrombus imaging and patient clinical data only, and one
derived from the combined set of imaging and clinical features. For the
imaging model, multivariate logistic regression (MLR) as provided in the code
was used to select features, while for the clinical model statistical analysis
was performed to select features individually based on statistical significance.

4.2.4.1 Feature extraction and selection
To select imaging features, a total of 4 shape (size, volume, solidity,
eccentricity) and 43 texture features (supplementary Table 4-1) were
extracted from each segmented thrombus’ R2*, QSM and FF maps. Feature
extraction was performed under the possible 8 combinations of the following
extraction parameters: 8, 16, 32 or 64 total gray levels, with uniform or
equal-probability quantization. Images of a representative thrombus before
and after quantization are shown in Figure 4-1. Imaging features were
selected using imbalanced-adjusted MLR, where models were derived of 1 to
10

variables

(model

order)

by

maximizing

the

receiver-operating

characteristic (ROC) curve using the 0.632+ bootstrap method (AUC632+)31 to
differentiate between CE and LAA stroke.20 Features included in the model
with highest AUC632+ of the lowest model order were selected to build the
imaging random forest model.
For clinical variables, individual clinical parameters found to differ between
CE and LAA patients within the training cohort to a level of P < .1 were
selected as the features for the clinical random forest model. The combined
random forest model utilized the selected features from both models.
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Figure 4-1: Representative segmented thrombus R2* (top), QSM (middle) and
FF (bottom) images shown in (A) original form, (B) after equal-probability
quantization with 64 bins and (C) after uniform quantization with 8 bins.
These extraction parameters control the pixel distribution and coarseness
under which features are extracted, respectively.

4.2.4.2 Random forest analysis
The random forest classifier was used as it is capable of incorporating
numerical and categorical data and has been shown to create highly
generalizable models.32 Random forest classifiers were built using 500 trees
trained on bootstrapped samples from the training cohort, and were tested on
the “out-of-bag” measurements from the training cohort and using all trees on
the validation cohort. Overall AUC, sensitivity, specificity and accuracy of the
predicted, compared to clinically determined, stroke etiology were recorded
for each classifier model.
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4.2.5 Statistical analysis
Clinical data are displayed as mean ± standard deviation and count
(percentage) for numerical and categorical variables, respectively. One-way
analysis of variance and chi-squared tests were used to assess differences in
numerical and categorical clinical variables, respectively, between CE and
LAA strokes in the training cohort. Statistical analysis was performed using
SPSS (version 23; IBM, Armonk, NY); P < .05 was considered statistically
significant.

4.3 Results
In this study 128 thrombi were collected from 78 patients, however after
excluding patients based on refused consent (n=1), recent prior stroke (n=3)
or non-CE or LAA etiology (embolic stroke of undetermined source: n=12;
dissection: n=2; unknown: n=2), a total of 91 thrombi from 58 patients were
available. 76 thrombi from 49 patients were included in the training cohort
while 15 thrombi from 9 patients were included in the validation cohort.
Differences in clinical characteristics between CE and LAA stroke within the
training cohort are shown in Table 4-2. Patients with CE stroke were
significantly older, and had significantly lower incidence of smoking,
triglyceride levels and trended towards lower incidence of hemorrhagic
transformation; these four variables were selected as features for the clinical
random forest model.
Multivariate logistic regression performed on the image features extracted
from thrombus R2*, QSM and FF maps in the training cohort yielded an
optimal model order of 4. The identified features selected for the imaging
random forest model and are listed in Table 4-3. Notably, only features from
thrombus QSM and FF maps were selected. A CE stroke etiology was
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associated with higher skewness in overall QSM values, lower variance in
overall FF values, higher variance in QSM gray-level run lengths, and more
outliers in QSM size zone matrices. Hence, CE stroke was associated with
lower variability in thrombus FF values and higher variability and
inconsistency in QSM values.
The performance of the imaging, clinical and combined models for stroke
etiology prediction in both cohorts is listed in Table 4-4; respective ROC
curves are shown in Figure 4-2. AUC values of each model were always
higher when forming predictions on the training cohort than the validation
cohort, as expected. Within each cohort, the combined model produced the
highest AUC value, followed by the clinical and then image-texture model.
The combined classifier achieved an AUC and accuracy of 0.893 and 93%,
respectively, for predicting stroke etiology in the validation cohort.
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Table 4-2: Clinical details of CE and LAA strokes within the training cohort
Characteristic
CE (n = 41)
LAA (n = 8)
P value
Age (years)
Sex, female
Prior stroke
Prior TIA
Hypertension
Diabetes
Hyperlipidemia
Coronary artery disease
Cardiac valve disease
Peripheral artery disease
Smoking, past 5 years
Past DVT
Chronic kidney disease
Obesity
Infection, past 30 days
Active cancer
Antiplatelets
Anticoagulants
IV rtPA
Hemorrhagic transformation
Stroke recurrence
TICI score:
0
1
2A
2B
3
Arrival NIHSS (median (IQR))
Occlusion side:
Right
Left
Unknown
Occlusion site:
ICA
ICA + MCA M1
MCA M1
MCA M1 + M2
MCA M2
Vertebrobasilar
EVT passes
EVT duration (minutes)
Triglycerides (mM/L)
Cholesterol (mM/L)
HDL (mM/L)
LDL (mM/L)
Glucose (hemoglobin A1c; %)
Leukocytes (109/L)
Troponin (ng/L)

74 ± 15
18 (44%)
8 (20%)
2 (5%)
30 (73%)
5 (12%)
19 (46%)
10 (24%)
4 (10%)
3 (7%)
2 (5%)
0 (0%)
0 (0%)
1 (2%)
2 (5%)
0 (0%)
15 (37%)
10 (24%)
14 (34%)
12 (29%)
2 (25%)

61 ± 10
2 (25%)
2 (25%)
1 (13%)
4 (50%)
1 (13%)
4 (50%)
0 (0%)
0 (0%)
0 (0%)
3 (38%)
0 (0%)
0 (0%)
1 (13%)
0 (0%)
0 (0%)
4 (50%)
0 (0%)
4 (50%)
5 (63%)
5 (12%)

1 (2%)
2 (5%)
2 (5%)
10 (24%)
26 (63%)
18 (15.5 - 22.5)

0 (0%)
0 (0%)
0 (0%)
3 (38%)
5 (63%)
9 (5.25 - 9)

21 (51%)
16 (39%)
4 (10%)

3 (38%)
4 (50%)
1 (13%)

3 (7%)
7 (17%)
18 (44%)
3 (7%)
6 (15%)
4 (10%)
1.7 ± 1.4
54 ± 35
1.3 ± 0.7
3.6 ± 0.8
1.0 ± 0.4
1.9 ± 0.7
5.7 ± 0.7
8.8 ± 2.6
47 ± 71

0 (0%)
2 (25%)
2 (25%)
0 (0%)
3 (38%)
1 (13%)
1.7 ± 1.9
95 ± 41
3.6 ± 3.2
5.1 ± 1.3
0.9 ± 0.3
2.8 ± 1.0
7.2 ± 2.2
9.2 ± 2.1
14 ± 12

0.028
0.320
0.725
0.411
0.193
0.981
0.850
0.117
0.357
0.430
0.005
0.118
0.524
0.476
0.117
0.395
0.071
0.344
0.842

0.361
0.680

0.558

0.813
0.412
0.008
0.325
0.259
0.531
0.276
0.494
0.255

Abbreviations: TIA, transient ischemic attack; DVT, deep vein thrombosis; TICI,
thrombolysis in cerebral infarction; NIHSS, National Institutes of Health stroke scale;
MCA, middle cerebral artery; ICA, internal carotid artery; IV rtPA, intravenous
recombinant tissue plasminogen activator; EVT, endovascular therapy; HDL, highdensity lipoprotein; LDL, low-density lipoprotein.
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Table 4-3: Thrombus MR imaging texture features selected by MLR for
differentiating CE and LAA stroke within the training cohort
Quantization
Number of Texture type
Texture name
Image type
algorithm
gray levels
QSM
Equal-probability
16
Global
Skewness
FF
Equal-probability
16
Global
Variance
QSM
Uniform
32
GLRLM
RLV
QSM
Equal-probability
8
GLSZM
GLN
Abbreviations: MLR, multi-variate logistic regression; QSM, quantitative
susceptibility mapping; FF, fat fraction; GLRLM, gray-level run-length
matrix; RLV, run-length variance; GLSZM, gray-level size zone matrix; GLN,
gray-level non-uniformity.
Table 4-4: Performance of random forest classifiers for stroke etiology prediction
Patient cohort
Features used
AUC Sensitivity (%) Specificity (%) Accuracy (%)
Training
Imaging
0.79
66.7
78.7
76.3
Clinical
0.85
62.5
90.2
83.7
Imaging + clinical 0.96
87
95.1
93.4
Validation
Imaging
0.68
57.1
75
66.7
Clinical
0.80
100
80
88.9
Imaging + clinical 0.89
100
87.5
93.3

Figure 4-2: ROC curves for the determination of CE vs. LAA stroke etiology
within the training (A) and validation (B) cohorts using the imaging, clinical
and combined random forest classifier models.
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4.4 Discussion
This study demonstrates the capability of both thrombus MR imaging and
patient clinical data features for the prediction of ischemic stroke etiology.
Our imaging texture features were derived from thrombi scanned ex vivo,
obviating the need to perform in vivo imaging on vulnerable stroke patients,
while all clinical data included in this study can be accessed through a review
of patient clinical history, outcome of stroke therapy, and a blood test.
Features from each of these data types alone were sufficient to predict stroke
etiology with reasonable accuracy, but when combined yielded a model which
predicted stroke etiology in an independent test set with a high degree of
accuracy.
Thrombus imaging texture models have previously been developed to form
predictions related to stroke. Thrombus CT texture features were used in two
studies to predict early recanalization following rtPA and EVT therapies,
respectively;25,26 neither study involved patient clinical data in their analysis.
Recently, a study by Chung et al. used features extracted from transverse
line profiles of thrombus GRE blooming artifact to predict stroke etiology.33
This study tested multiple machine learning classifiers and also did not
incorporate clinical data. Their highest AUC of 0.93 was reached using
random forest and logistic regression models, but achieved accuracies of only
75 and 77%, respectively. Thrombus GRE blooming artifact appearance has
been shown to vary between scanners,34 suggesting that measurements
obtained from these qualitative images may not be widely generalizable. In
contrast, the current study uses features extracted from quantitative MR
maps, and incorporates information beyond susceptibility-based information
(fat fraction). Multiple studies have examined associations between patient
clinical variables and stroke etiology, and older age and lower incidence of
smoking have consistently been associated with cardioembolism. 35-38 These
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studies did not assess triglyceride levels or intracerebral hemorrhage
occurrence, but separate studies examining hemorrhagic transformation
incidence following ischemic stroke treatment have identified lipid levels and
etiology as associated risk factors.39,40
In this study we created random classifier models using four imaging, four
clinical and eight combined total features. Both the imaging and clinical-only
models were able to form accurate predictions of stroke etiology, however the
imaging-only model was outperformed by the clinical-only model in both the
training and validation cohorts. This suggests that the thrombus texture
features may not be as predictive or generalizable as clinical features when
considered independently. Conflicting results have been reported on the
associations between thrombus composition and etiology,3,5,6 which would
affect imaging features, while CT texture features have been questioned for
their inter-scanner variability and sensitivity to acquisition parameters. 41
Nonetheless, the combined model outperformed both isolated models in the
training and validation cohorts, suggesting that the imaging and clinical
features provided independent and complimentary information for forming
etiology predictions.
Of the thrombus features selected in the imaging model, only features from
QSM and FF maps were selected, while R2* went unused. Similar to QSM, R2*
is sensitive to hemoglobin-induced susceptibility effects but holds a quadratic
relationship with RBC content, unlike QSM which is linear.10,42 It is possible
that information derived from thrombus R2* pixel distributions is less
informative of RBC content than those from QSM, due to similarity in R 2*
values of thrombi in the region between 40-60% RBC content.10 The higher
variance and presence of outliers within QSM values of CE thrombi suggests
that their RBCs may be more deoxygenated than those of LAA thrombi. In
contrast to R2* and QSM, FF provides a unique assessment of thrombus lipid
content; the finding of higher variance in FF values of LAA thrombi and
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higher triglyceride levels in LAA patients suggests that LAA thrombi may be
composed of higher, more variable amounts of lipid due to high triglyceride
levels in the blood. The few studies that have identified lipid content within
histologically analyzed stroke thrombi have done so exclusively with LAA
thrombi.43-45
For this study, we used ex vivo imaging features derived from retrieved
stroke thrombi, and clinical features available as part of standard stroke
patient assessment. We have therefore demonstrated our models’ utility only
for ex vivo thrombus examination, but with this method it is easier to recruit
patients and avoids the challenges associated with scanning acute stroke
patients prior to treatment. All clinical features utilized in this paper are
readily accessible through a review of patients’ clinical history, outcome of
stroke treatment, and the results of blood tests. Taken together, all
components of the developed models are relatively easily accessible to
clinicians, do not require in vivo stroke patient scans, and provide accurate
predictions of etiology which may enable differentiation of CE and LAA
stroke much sooner than with long term electrocardiographic monitoring.
This study has a number of limitations. Our sample size was small,
particularly for the validation cohort. Recruitment for this cohort was cut
short due to the COVID-19 pandemic, and sample size was further limited by
including only patients with known CE or LAA etiologies. Thrombus imaging
was conducted ex vivo, meaning we cannot assess the capability of this
method for in vivo scans. Chosen scan parameters and acquisition hardware
were selected to be directly translatable to in vivo head imaging, and hence
were not optimized for ex vivo samples. It is possible the retrieved stroke
thrombi could have different imaging feature values if scanned in vivo, due to
the forces exerted on the thrombus by vessel occlusion which may influence
texture features, physical alterations to the thrombus during and following
the EVT procedure, and differences in temperature and field inhomogeneity
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from performing scans ex vivo. The fact that only successfully retrieved
thrombi were included in the study introduces bias through excluding
thrombi which could not be retrieved by EVT or which resolved following
rtPA administration. Multiple thrombi retrieved from patients were analyzed
separately and treated as independent, though correlation between their
imaging values is likely. Assessment of thrombus histological RBC content
may have improved model performance but was not included. A prospectively
recruited cohort of patients is required to evaluate the clinical utility of the
stroke etiology predictions made by the machine learning models.

4.5 Conclusion
In this study, we demonstrated that features derived from ex vivo thrombus
MR imaging and patient clinical data can be used independently or in
combination to differentiate between CE and LAA ischemic stroke. Our
combined machine learning model generated highly accurate predictions of
stroke etiology, and outperformed the models derived from imaging and
clinical data alone. The rapid ex vivo imaging protocol and readily available
clinical features used in this study makes this method widely applicable for
aiding acute ischemic stroke etiology diagnosis.
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4.7 Supplementary material
Supplementary Table 4-1: Texture features used in this study; more detail
available in Vallières et al. 2015
Texture type
Texture name
Variance
Global
Skewness
Kurtosis

Gray-level co-occurrence
matrix (GLCM)

Energy
Contrast
Correlation
Homogeneity
Variance
Sum Average
Entropy
Autocorrelation

Gray-level run-length matrix
(GLRLM)

Short Run Emphasis (SRE)
Long Run Emphasis (LRE)
Gray-Level Non-uniformity (GLN)
Run-Length Non-uniformity (RLN)
Run Percentage (RP)
Low Gray-Level Run Emphasis (LGRE)
High Gray-Level Run Emphasis (HGRE)
Short Run Low Gray-Level Emphasis (SRLGE)
Short Run High Gray-Level Emphasis (SRHGE)
Long Run Low Gray-Level Emphasis (LRLGE)
Long Run High Gray-Level Emphasis (LRHGE)
Gray-Level Variance (GLV)
Run-Length Variance (RLV)

Gray-level size zone matrix
(GLSZM)

Small Zone Emphasis (SZE)
Large Zone Emphasis (LZE)
Gray-Level Non-uniformity (GLN)
Zone-Size Non-uniformity (ZSN)
Zone Percentage (ZP)
Low Gray-Level Zone Emphasis (LGZE)
High Gray-Level Zone Emphasis (HGZE)
Small Zone Low Gray-Level Emphasis (SZLGE)
Small Zone High Gray-Level Emphasis
(SZHGE)
Large Zone Low Gray-Level Emphasis (LZLGE)
Large Zone High Gray-Level Emphasis
(LZHGE)
Gray-Level Variance (GLV)
Zone-Size Variance (ZSV)

Neighbourhood gray-tone
difference matrix (NGTDM)

Coarseness
Contrast
Busyness
Complexity
Strength
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CHAPTER 5

Conclusions and Future Directions

5.1 Conclusions
Stroke thrombus MR imaging has been previously examined as means to
provide additional information to improve the treatment of acute ischemic
stroke. However, past methods tested in vivo have utilized unreliable
qualitative metrics, while more advanced, quantitative techniques have thus
far been limited almost exclusively to in vitro or preclinical experiments. The
work of this thesis serves to expand the capability of MR in stroke thrombus
imaging, specifically by exploiting quantitative information and advanced
artificial intelligence techniques applied to thrombus ex vivo images for the
prediction of ischemic stroke etiology.
In Chapter 2, I demonstrate that blood clot R2* and QSM values are each
sensitive to RBC content and oxygenation. This accords with the findings of
previous in vitro clot studies, however this work was the first to examine
these MR parameters on clots of simultaneously varied composition and
oxygenation. I show that clot R2* and QSM values vary drastically as their
oxygenation evolves throughout ageing, and importantly that these changes
dominate the inherent differences found between clots of different RBC
content. Because of this, the examination of either R2* or QSM alone will not
be sufficient to determine RBC content in acute stroke thrombi, where
oxygenation is never known. I devised a metric using the ratio of clot R 2* to
QSM values and showed that it allowed prediction of RBC content
independent of oxygenation, suggesting that a multiparametric approach
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may enable accurate RBC content determination in stroke thrombi.
Additionally, I demonstrated that FF and QSM mapping are capable of
detecting lipidic and calcified components within blood clots, respectively,
regardless of composition or oxygenation; the identification of these
uncommon components within stroke thrombi would be directly informative
of

etiology.

Overall,

this

work

established

the

potential

of

our

multiparametric, quantitative MR imaging method for the characterization of
ischemic stroke thrombi.
In Chapter 3, I applied a deep learning CNN to ex vivo stroke thrombus R2*,
QSM and GRE images to predict histological RBC content. To my knowledge,
this is the first study to use deep learning to analyze MR images of stroke
thrombi. I demonstrate that CNNs are capable of leveraging the information
available within our multiparametric MR dataset to form accurate
predictions of thrombus RBC content, specifically with a mean absolute error
of approximately 8%. The small number of thrombi available for this study
and the improvements in network accuracy observed when applying data
augmentation suggest that greater network performance is achievable if
trained on a larger dataset.
Finally, in Chapter 4, I present a machine learning approach employing
radiomics texture features extracted from thrombus R2*, QSM and FF maps
along with clinical patient data to predict stroke etiology. Similar methods
have been employed on thrombus CT images to predict response to rtPA and
endovascular therapies,1,2 however to my knowledge this was the first
application of machine learning on thrombus texture features for stroke
etiology prediction. The models achieved accurate etiology prediction with
AUC and accuracy values of 0.68 and 67%, respectively, using thrombus
texture information alone, 0.8 and 89% using clinical information alone, and
0.89 and 93% when using both sets of features. Relative to previous work
utilizing qualitative imaging signs for etiology prediction which have
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achieved accuracies of 49%,3 and clinical models which have achieved AUC
values of 0.85,4 the combined model outperformed past attempts and has
yielded a novel, promising method to improve clinical etiology determination
in acute ischemic stroke.

5.2 Limitations
5.2.1 Analysis of blood clot RBC, lipid and calcium content
The limitations of the study presented in Chapter 2 stem largely from its in

vitro design; each component included in clot construction was mimicking a
pathological human process. In particular, clots were prepared from porcine
blood and thus may possess innately different relaxation and susceptibility
values than that of human thrombi. Additionally, the mechanisms underlying
human thrombus formation are various and complex, and yield thrombi of
heterogeneous structure.5,6 The clots prepared for this study

were

comparatively simplistically derived, large and homogeneous in structure.
Another key facet of this study was allowing the initially fully oxygenated
arterial clots’ oxygenation to change naturally through in vitro ageing, which
was meant to traverse the breadth of possible oxygenation values observable
in human thrombi. While measurement of stroke thrombus oxygenation in

vivo has not been previously investigated, it is likely to be affected by the
environment in which thrombosis occurs, the age of the thrombus prior to
embolization, and the duration and severity of the stroke at the time of
imaging. It is unlikely that all plausible stroke thrombus oxygenation states
were represented through our static in vitro clot ageing procedure.
Finally, I used lab materials to represent the lipid and calcified components
that can found within stroke thrombi. Despite similar MR properties, these
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materials do not exactly mimic the components found in stroke thrombi, nor
is their inclusion as a single large piece of material representative of the all
possible component distributions, which may also be diffuse or punctate.

5.2.2 Prediction of stroke thrombus RBC content
The principle limitation of the 3rd Chapter study is that the thrombi were
scanned ex vivo, following endovascular retrieval, rather than in stroke
patients in vivo. While our MR sequence was designed for in vivo imaging
and may be translated without alteration of any sequence parameters,
differences in field inhomogeneity, shimming and temperature could all affect
observed thrombus MR parameters. Scanning in vivo presents additional
challenges to scan acquisition including flow artifact and patient movement.
Our study is biased by the ability to only include thrombi retrievable by
endovascular

therapy,

and

which

did

not

resolve

following

rtPA

administration if given. As part of the retrieval thrombus breakage or
alterations to its size and shape may have occurred which could influence
observed MR parameters. Additionally, alterations to thrombus oxygenation
or structure can occur during storage, the time between thrombus retrieval
and ex vivo scanning. Thrombus segmentation was also not fully automatic
and additional bias could have been introduced in this step.
The study was further limited by its small sample size. The inclusion of just
under 50 thrombi meant that I did not have enough samples to apportion a
meaningful test set, and instead used cross-validation to evaluate the
network; this may result in overestimation of the generalizability of the
model.7 Small sample size is a common limitation for deep learning studies in
general, which are notorious for using massive datasets to derive
generalizable models; the improvements observed when

using

data
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augmentation to increase effective dataset size suggest that a larger sample
cohort would be highly beneficial to the performance of the network.
Our study relied on histological analysis to derive ground-truth values of
thrombus RBC content. These were derived from a single histology slice and I
made the assumption that the measured RBC content was representative of
each thrombus overall, and that the RBC content within every MR slice of
each thrombus was identical to the histological value.

5.2.3 Prediction of stroke etiology
With the exception of an independent test dataset and the use of histology, all
limitations of the study detailed in Chapter 3 also apply to the study
described in Chapter 4. This was also an ex vivo imaging study, but here
radiomics texture features and clinical data were used to form predictions of
stroke etiology using machine learning. Radiomics texture features can be
influenced by a number of factors including acquisition parameters and the
scanner used;8 features extracted from ex vivo thrombus images may vary
from those acquired in vivo. As with any machine learning study, model
performance is influenced by the particular texture and clinical features
chosen a priori for study. Sample size is also a limitation (n = 91 thrombi),
though more samples were able to be included in this study than that of
Chapter 3 because histological analysis was not required.

5.3 Future directions
This thesis presents a quantitative, multiparametric MR technique for
thrombus analysis to aid in the treatment and management of acute ischemic
stroke. It is motivated by in vitro work demonstrating capability of our
sequence for thrombus analysis, and is followed by ex vivo work
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demonstrating utility in human stroke thrombi. Besides translation of the
technique to in vivo studies to directly assess clinical utility, there are a
multitude of additional applications where our quantitative thrombus
imaging technique may prove useful, as well as areas where the technique
may be improved. These are detailed in the following sections ordered by the
types of experiments to be performed.

5.3.1 In vitro
Histological studies have reported that CE thrombi have lower RBC content
than LAA thrombi,9,10 yet MR imaging studies have consistently found a
higher presence of susceptibility signs in CE compared to LAA stroke.3,11,12
This suggests that, in spite of lower overall RBC content, RBCs in CE
thrombi tend to be drastically more deoxygenated than those found in LAA
thrombi. Measurement of RBC oxygenation state could therefore provide an
additional means to predict stroke etiology which complements assessment of
RBC proportion.
Measurement of the T1 relaxation rate in RBCs can indicate methemoglobin
content, one of the two forms of deoxygenated hemoglobin found within
thrombi.13 Because R2* and QSM are sensitive to deoxygenated hemoglobin
but insensitive to form (deoxy- or methemoglobin), the addition of the T1
parameter to the multiparametric analysis may allow explicit determination
of the proportions of oxy-, deoxy- and methemoglobin content in thrombi. An

in vitro blood study which related the MR parameters of oxygenated
(arterial), deoxygenated (venous) and methemoglobin-rich (aged) blood to an
independent oximetry technique such as blood gas analysis could allow
mapping of MR parameters to the amount of each hemoglobin form in blood
clots. Applied to stroke thrombi, such analyses may be indicative of thrombus
age and provide an additional means to infer etiology. The inclusion of T 1
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measurement would require an additional sequence to be added to the
protocol however, necessitating increased scan time.

5.3.2 Ex vivo
A number of additional parameters related to stroke treatment remain to be
studied for associations with thrombus MR imaging. Our technique is
sensitive to thrombus RBC content, which has been directly related to
response to endovascular therapy (procedure time, number of passes,
recanalization score).9,14,15 Machine learning applied to CT thrombus texture
features, as well as mean thrombus R2* values have each been previously
used

to

predict

response

to

endovascular

therapy,2,16

however

multiparametric MRI and more advanced data analysis techniques such as
deep learning have not been used for this application and may yield superior
predictions. Though likely correlated to therapy response, associations
between thrombus properties and long term stroke outcome is an
understudied area of research where MR machine learning or deep learning
analysis could also be informative.

5.3.3 In vivo
Despite demonstrating potential, our study of etiology prediction from
thrombus MR features needs to be replicated prospectively in vivo to
accurately assess its capability to aid in acute ischemic stroke care. MR
images from a pilot study showing time of flight (TOF) angiography and R2*,
QSM and FF maps of an ischemic stroke patient with intracranial thrombus

in vivo are shown in Figure 5-1. In vivo imaging studies additionally enable
the study of thrombi which could not be retrieved for ex vivo study, allowing
associations

with

complications

including

secondary

embolism

or

intracerebral hemorrhage, or failed retrieval by endovascular therapy or
successful thrombolysis to be drawn. The latter has been examined in
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machine learning studies of thrombus CT texture features,1,2 but to my
knowledge has never been investigated with quantitative MR imaging.

Figure 5-1: Axial time of flight (TOF) angiography, R2*, QSM and FF maps of
an ischemic stroke patient with intracranial thrombus (arrow) of
atherothrombotic origin. High R2* and QSM indicate a deoxygenated, RBCrich thrombus, while a high FF suggests the presence of lipid (from plaque
core).
For any in vivo analysis technique to be useful in the acute stroke setting,
rapid derivation of results is required. To this end, the use of semi-automated
segmentation is the biggest limitation of the work described in this thesis;
automated in vivo thrombus segmentation is a necessary step for the
development of a clinically practical thrombus MR analysis tool. Secondary
processing steps including the image post-processing required to derive our
quantitative MR parameters could be hastened by translating our Matlab
code to more efficient programming languages and using more powerful
processors for computation. While both machine and deep learning models
are computationally expensive to derive, once trained they are extremely
efficient for analyzing new data.
Even if a rapid, fully automated thrombus analysis tool existed, ischemic
stroke is a challenging application as, in Canada, acute stroke patients are
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not typically triaged using MRI. While the utilization of MR imaging in acute
ischemic stroke care is expected to increase following recent changes to
clinical guidelines,17 its use is still rare due to its relatively long scan times
compared to CT and so additional clinical applications lacking rigid time
restrictions should be considered. Thrombus age in deep vein thrombosis
influences the success rate of fibrinolysis, but remains challenging to
determine;18 the use of imaging to predict deep vein thrombosis thrombus age
is an active area of study that has currently seen little employment of
quantitative techniques.19 Atherosclerotic plaque imaging and cerebral
venous thrombosis are other areas where knowledge of associated thrombus
age and composition may be useful for determining the course of therapy.
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enables differentiation of thrombus hematocrit and age: an in vitro study at 3
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